[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 89 of about 89
1. Puñal Vidal L, Suárez Peñaranda JM, Rossi Izquierdo M, Dios Loureiro C, Labella Caballero T, Forteza Vila J: [Laryngeal adenocarcinoma: case report]. Acta Otorrinolaringol Esp; 2008 Dec;59(10):500-2

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Laryngeal adenocarcinoma: case report].
  • [Transliterated title] Adenocarcinoma de laringe: presentación de un caso.
  • Laryngeal adenocarcinomas are extremely unusual (only 0.35 %-0.5 % of all laryngeal malignancies).
  • We report a case of a 64-year-old man with an adenocarcinoma of the larynx with cervical lymph node involvement at the moment of the diagnosis.
  • [MeSH-major] Adenocarcinoma. Laryngeal Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Acta Otorrinolaringol Esp. 2009 Jan-Feb;60(1):78. Puñal Vidal, Luis [corrected to Puñal Vidal, Lidia]
  • (PMID = 19080787.001).
  • [ISSN] 0001-6519
  • [Journal-full-title] Acta otorrinolaringológica española
  • [ISO-abbreviation] Acta Otorrinolaringol Esp
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


2. Iqbal FR, Sani A, Gendeh BS, Aireen I: Triple primary cancers of the larynx, lung and thyroid presenting in one patient. Med J Malaysia; 2008 Dec;63(5):417-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Triple primary cancers of the larynx, lung and thyroid presenting in one patient.
  • Lung malignancies presenting in association with head and neck tumours are well documented while there have been small series of thyroid synchronous cancers presenting with laryngeal lesions in literature.
  • No cases, to our knowledge, have been reported in literature of a single patient with all three laryngeal, lung and thyroid malignancies.
  • We report one such case of a 71-year-old Chinese man who had undergone a total laryngectomy for a recurrent cancer of the larynx only to be found to have tumours of the lung and thyroid in the post-operative period and he eventually died of post-operative complications.
  • [MeSH-major] Adenocarcinoma / diagnosis. Carcinoma, Papillary / diagnosis. Carcinoma, Squamous Cell / diagnosis. Laryngeal Neoplasms / diagnosis. Lung Neoplasms / diagnosis. Neoplasms, Multiple Primary / diagnosis. Thyroid Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19803306.001).
  • [ISSN] 0300-5283
  • [Journal-full-title] The Medical journal of Malaysia
  • [ISO-abbreviation] Med. J. Malaysia
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Malaysia
  •  go-up   go-down


3. Jones SJ, Laskin J, Li YY, Griffith OL, An J, Bilenky M, Butterfield YS, Cezard T, Chuah E, Corbett R, Fejes AP, Griffith M, Yee J, Martin M, Mayo M, Melnyk N, Morin RD, Pugh TJ, Severson T, Shah SP, Sutcliffe M, Tam A, Terry J, Thiessen N, Thomson T, Varhol R, Zeng T, Zhao Y, Moore RA, Huntsman DG, Birol I, Hirst M, Holt RA, Marra MA: Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors. Genome Biol; 2010;11(8):R82
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors.
  • We investigated the utility of massively parallel sequencing to characterize an adenocarcinoma of the tongue, before and after treatment.
  • [MeSH-major] Adenocarcinoma / genetics. Adenocarcinoma / pathology. Gene Expression Regulation, Neoplastic / drug effects. Protein Kinase Inhibitors / pharmacology. Proto-Oncogene Proteins c-ret / genetics

  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. NICOTINAMIDE .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nucleic Acids Res. 2001 Jan 1;29(1):308-11 [11125122.001]
  • [Cites] Neoplasia. 1999 Jun;1(2):101-6 [10933042.001]
  • [Cites] Clin Cancer Res. 2003 Oct 1;9(12):4340-6 [14555504.001]
  • [Cites] Auris Nasus Larynx. 2004 Mar;31(1):85-8 [15041060.001]
  • [Cites] Laryngoscope. 1987 May;97(5):533-6 [3573898.001]
  • [Cites] Genes Chromosomes Cancer. 1994 Aug;10(4):256-61 [7522539.001]
  • [Cites] Science. 1995 Oct 20;270(5235):484-7 [7570003.001]
  • [Cites] J Laryngol Otol. 1996 Jul;110(7):700-3 [8759555.001]
  • [Cites] Otolaryngol Head Neck Surg. 1997 Nov;117(5):448-52 [9374165.001]
  • [Cites] J Cell Biol. 1998 Nov 30;143(5):1375-83 [9832564.001]
  • [Cites] Diagn Mol Pathol. 2005 Jun;14(2):77-82 [15905690.001]
  • [Cites] Lab Invest. 2005 Sep;85(9):1076-85 [16025147.001]
  • [Cites] Nat Rev Drug Discov. 2005 Dec;4(12):988-1004 [16341064.001]
  • [Cites] Nucleic Acids Res. 2006 Jan 1;34(Database issue):D668-72 [16381955.001]
  • [Cites] Bioinformatics. 2006 Jul 15;22(14):e431-9 [16873504.001]
  • [Cites] BMC Genomics. 2006;7:246 [17010196.001]
  • [Cites] Science. 2006 Oct 13;314(5797):268-74 [16959974.001]
  • [Cites] Br J Cancer. 2006 Dec 4;95(11):1562-7 [17088901.001]
  • [Cites] Nat Rev Cancer. 2007 Jan;7(1):35-45 [17167516.001]
  • [Cites] Am J Surg Pathol. 2007 Feb;31(2):240-6 [17255769.001]
  • [Cites] Nature. 2007 Mar 8;446(7132):153-8 [17344846.001]
  • [Cites] Lung Cancer. 2007 Apr;56(1):25-33 [17175059.001]
  • [Cites] Cancer Res. 2007 Jun 15;67(12):5779-88 [17575145.001]
  • [Cites] Gynecol Oncol. 2007 Jul;106(1):94-104 [17490733.001]
  • [Cites] PLoS Biol. 2007 Sep 4;5(10):e254 [17803354.001]
  • [Cites] Science. 2007 Nov 16;318(5853):1108-13 [17932254.001]
  • [Cites] Biochem Biophys Res Commun. 2008 Mar 7;367(2):291-8 [18155156.001]
  • [Cites] Nature. 2008 Apr 17;452(7189):872-6 [18421352.001]
  • [Cites] Nat Genet. 2008 Jun;40(6):722-9 [18438408.001]
  • [Cites] Nat Methods. 2008 Jul;5(7):621-8 [18516045.001]
  • [Cites] Biotechniques. 2008 Jul;45(1):81-94 [18611170.001]
  • [Cites] Science. 2008 Sep 26;321(5897):1801-6 [18772397.001]
  • [Cites] Nature. 2008 Oct 23;455(7216):1069-75 [18948947.001]
  • [Cites] Genome Res. 2008 Nov;18(11):1851-8 [18714091.001]
  • [Cites] Nature. 2008 Nov 6;456(7218):53-9 [18987734.001]
  • [Cites] Nature. 2008 Nov 6;456(7218):66-72 [18987736.001]
  • [Cites] BMC Genomics. 2008;9:488 [18925949.001]
  • [Cites] Nucleic Acids Res. 2009 Jan;37(Database issue):D690-7 [19033362.001]
  • [Cites] PLoS One. 2009;4(1):e4108 [19119315.001]
  • [Cites] Biochem Pharmacol. 2009 Feb 1;77(3):297-309 [19028457.001]
  • [Cites] N Engl J Med. 2009 Jun 25;360(26):2719-29 [19516027.001]
  • [Cites] Genome Res. 2009 Sep;19(9):1639-45 [19541911.001]
  • [Cites] Nature. 2009 Oct 8;461(7265):809-13 [19812674.001]
  • [Cites] Cancer Res. 2010 Feb 1;70(3):1063-71 [20103651.001]
  • [Cites] Nat Genet. 2010 Feb;42(2):181-5 [20081860.001]
  • [Cites] Cancer Res. 1999 Nov 1;59(21):5403-7 [10554005.001]
  • [Cites] Nucleic Acids Res. 2000 Jan 1;28(1):27-30 [10592173.001]
  • [Cites] Nat Rev Cancer. 2001 Dec;1(3):222-31 [11902577.001]
  • (PMID = 20696054.001).
  • [ISSN] 1474-760X
  • [Journal-full-title] Genome biology
  • [ISO-abbreviation] Genome Biol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Benzenesulfonates; 0 / Indoles; 0 / Neoplasm Proteins; 0 / Phenylurea Compounds; 0 / Protein Kinase Inhibitors; 0 / Pyridines; 0 / Pyrroles; 0 / sunitinib; 25X51I8RD4 / Niacinamide; 9ZOQ3TZI87 / sorafenib; EC 2.7.10.1 / Proto-Oncogene Proteins c-ret; EC 2.7.10.1 / RET protein, human; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt; EC 2.7.11.24 / Mitogen-Activated Protein Kinases
  • [Other-IDs] NLM/ PMC2945784
  •  go-up   go-down


Advertisement
4. Sano D, Matsuda H, Yoshida T, Kimura Y, Tanigaki Y, Mikami Y, Tsukuda M: A case of metastatic colon adenocarcinoma in the larynx. Acta Otolaryngol; 2005 Feb;125(2):220-2

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of metastatic colon adenocarcinoma in the larynx.
  • Metastatic carcinomas in the larynx are uncommon, and laryngeal tumors originating from the colon are extremely rare.
  • We report a case of metastatic laryngeal tumor originating from a colon adenocarcinoma in an 81-year-old female.
  • The diagnosis, route of metastasis, treatment and prognosis of metastatic laryngeal tumors are discussed.
  • [MeSH-major] Adenocarcinoma / secondary. Colonic Neoplasms / pathology. Colonic Neoplasms / surgery. Laryngeal Neoplasms / secondary. Laryngeal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15880957.001).
  • [ISSN] 0001-6489
  • [Journal-full-title] Acta oto-laryngologica
  • [ISO-abbreviation] Acta Otolaryngol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Norway
  •  go-up   go-down


5. Sheng LM, Zhang LZ, Xu HM, Zhu Y: Ascending colon adenocarcinoma with tonsillar metastasis: a case report and review of the literature. World J Gastroenterol; 2008 Dec 14;14(46):7138-40
The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for colon adenocarcinoma .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ascending colon adenocarcinoma with tonsillar metastasis: a case report and review of the literature.
  • A 53-year-old man presented with painless left palatine tonsillar swelling and a cervical mass following right hemicolectomy for an ascending colon adenocarcinoma.
  • A punch biopsy was taken for histological examination which showed a moderately-differentiated adenocarcinoma.
  • Our case shows that immunohistochemical diagnosis of metastatic palatine tonsil cancer is essential.
  • [MeSH-major] Adenocarcinoma / pathology. Colon, Ascending / pathology. Colonic Neoplasms / pathology. Tonsillar Neoplasms / diagnosis. Tonsillar Neoplasms / secondary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Surg Oncol. 2001 Apr;27(3):328-30 [11373114.001]
  • [Cites] Nucl Med Rev Cent East Eur. 2007;10(1):12-5 [17694495.001]
  • [Cites] J Laryngol Otol. 1999 Nov;113(11):1036-8 [10696391.001]
  • [Cites] Acta Otorhinolaryngol Ital. 2000 Aug;20(4):281-3 [11234447.001]
  • [Cites] J Laryngol Otol. 1971 Mar;85(3):289-92 [5576091.001]
  • [Cites] Otolaryngol Clin North Am. 1979 Feb;12(1):29-43 [220581.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1979 Mar-Apr;88(2 Pt 1):235-40 [443718.001]
  • [Cites] J Laryngol Otol. 1994 May;108(5):449-51 [8035134.001]
  • [Cites] Zhonghua Yi Xue Za Zhi (Taipei). 1996 Sep;58(3):209-12 [8940794.001]
  • [Cites] Otolaryngol Head Neck Surg. 1997 Apr;116(4):563-4 [9141413.001]
  • [Cites] J Otolaryngol. 1997 Oct;26(5):325-6 [9343772.001]
  • [Cites] Eur J Surg Oncol. 1999 Aug;25(4):439-40 [10419718.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1999 Sep;108(9):876-9 [10527279.001]
  • [Cites] Gastroenterol Clin Biol. 2005 Jan;29(1):70-2 [15738898.001]
  • [Cites] Clin Colorectal Cancer. 2005 Jul;5(2):108-13 [16098251.001]
  • [Cites] Mod Pathol. 2005 Sep;18(9):1217-22 [15803184.001]
  • [Cites] Jpn J Thorac Cardiovasc Surg. 2005 Aug;53(8):455-7 [16164261.001]
  • [Cites] Auris Nasus Larynx. 2006 Mar;33(1):85-8 [16169179.001]
  • [Cites] Otolaryngol Pol. 2006;60(1):97-100 [16821552.001]
  • [Cites] J Otolaryngol. 2006 Aug;35(4):227-34 [17176797.001]
  • [Cites] Community Dent Oral Epidemiol. 2007 Apr;35(2):98-108 [17331151.001]
  • [Cites] Arch Bronconeumol. 2007 Jun;43(6):309-16 [17583640.001]
  • [Cites] Otolaryngol Head Neck Surg. 1999 Nov;121(5):653-4 [10547490.001]
  • (PMID = 19084924.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] China
  • [Number-of-references] 23
  • [Other-IDs] NLM/ PMC2776847
  •  go-up   go-down


6. Avital I, Moreira AL, Klimstra DS, Leversha M, Papadopoulos EB, Brennan M, Downey RJ: Donor-derived human bone marrow cells contribute to solid organ cancers developing after bone marrow transplantation. Stem Cells; 2007 Nov;25(11):2903-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We identified four male patients who developed solid organ cancers (lung adenocarcinoma, laryngeal squamous cell carcinoma, glioblastoma, and Kaposi sarcoma) after myeloablation, total body irradiation, and ABMT from female donors.


7. Cui Y, Morgenstern H, Greenland S, Tashkin DP, Mao J, Cao W, Cozen W, Mack TM, Zhang ZF: Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus. Int J Cancer; 2006 Feb 1;118(3):714-20
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus.
  • We investigated the effects of XPG His1104Asp polymorphism (rs17655) on the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus (SCCOLE).
  • This population-based case-control study involves 611 new cases of lung cancer, 601 new cases of oropharyngeal, laryngeal and esophageal cancers, and 1,040 cancer-free controls.
  • The XPG polymorphism was assayed by PCR-RFLP method for 497 lung cancer cases, 443 cases of oropharyngeal, laryngeal and esophageal cancers and 912 controls.
  • [MeSH-major] Carcinoma, Squamous Cell / genetics. DNA-Binding Proteins / genetics. Endonucleases / genetics. Esophageal Neoplasms / genetics. Laryngeal Neoplasms / genetics. Lung Neoplasms / etiology. Nuclear Proteins / genetics. Oropharyngeal Neoplasms / genetics. Polymorphism, Genetic. Transcription Factors / genetics
  • [MeSH-minor] Adenocarcinoma / genetics. Adolescent. Adult. Alcohol Drinking. Carcinoma, Large Cell / diagnosis. Carcinoma, Large Cell / genetics. Carcinoma, Small Cell / diagnosis. Carcinoma, Small Cell / genetics. Case-Control Studies. DNA Repair. Female. Genetic Predisposition to Disease. Genotype. Humans. Male. Middle Aged. Odds Ratio. Polymerase Chain Reaction. Prognosis. Risk Factors. Tobacco

  • Genetic Alliance. consumer health - Lung Cancer.
  • Genetic Alliance. consumer health - Xeroderma pigmentosum.
  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 Wiley-Liss, Inc.
  • (PMID = 16094634.001).
  • [ISSN] 0020-7136
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA09142; United States / NCI NIH HHS / CA / CA77954; United States / NCI NIH HHS / CA / CA90833; United States / NCI NIH HHS / CA / CA96134; United States / NIDA NIH HHS / DA / DA11386; United States / NIEHS NIH HHS / ES / ES 011667
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA excision repair protein ERCC-5; 0 / DNA-Binding Proteins; 0 / Nuclear Proteins; 0 / Transcription Factors; EC 3.1.- / Endonucleases
  •  go-up   go-down


8. Marioni G, De Filippis C, Ottaviano G, Lorusso M, Staffieri C, Bernini G, Blandamura S: Laryngeal metastasis from sigmoid colon adenocarcinoma followed by peristomal recurrence. Acta Otolaryngol; 2006 Jun;126(6):661-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laryngeal metastasis from sigmoid colon adenocarcinoma followed by peristomal recurrence.
  • Considering clinical evidence,<2% of laryngeal malignancies are distant metastases.
  • Cutaneous melanomas are the preponderant primaries metastasizing to the larynx, followed by renal cell carcinomas, breast and lung carcinomas.
  • Colonic adenocarcinoma metastases to the larynx are extremely rare: only 13 cases have been described since 1972.
  • We present the first case of sigmoid colon adenocarcinoma metastasis to the larynx in a patient who developed peristomal malignancy recurrence after total laryngectomy.
  • Patients with metastasis of colonic adenocarcinoma to the larynx usually present with disseminated disease: in view of the poor chances of long-term survival of these patients conservative palliative laryngeal treatments should be carried out to improve the quality of life.
  • Curative treatment should be considered only in isolated laryngeal metastasis.
  • [MeSH-major] Adenocarcinoma / secondary. Laryngeal Neoplasms / secondary. Laryngectomy. Neoplasm Recurrence, Local / diagnosis. Sigmoid Neoplasms / diagnosis. Tracheostomy
  • [MeSH-minor] Aged. Biopsy, Needle. Female. Humans. Larynx / pathology. Lung Neoplasms / pathology. Lung Neoplasms / secondary. Lung Neoplasms / surgery. Reoperation. Thyroid Gland / pathology. Thyroid Neoplasms / pathology. Thyroid Neoplasms / secondary. Thyroid Neoplasms / surgery. Thyroidectomy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16720454.001).
  • [ISSN] 0001-6489
  • [Journal-full-title] Acta oto-laryngologica
  • [ISO-abbreviation] Acta Otolaryngol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Norway
  •  go-up   go-down


9. Storck C, Savic S, Egli J, Fischer C, Wolfensberger M: [Granular cell tumor of the larynx: a case report]. HNO; 2008 Dec;56(12):1229-32

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Granular cell tumor of the larynx: a case report].
  • [Transliterated title] Granularzelltumor des Larynx.
  • However, only about 200 cases of laryngeal granular cell tumors have been reported so far.
  • Most laryngeal granular cell tumors are located in the posterior part of the vocal fold and in the posterior commissure.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / therapy. Laryngeal Neoplasms / diagnosis. Laryngeal Neoplasms / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18340420.001).
  • [ISSN] 1433-0458
  • [Journal-full-title] HNO
  • [ISO-abbreviation] HNO
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


10. Omura Y: Asbestos as a possible major cause of malignant lung tumors (including small cell carcinoma, adenocarcinoma & mesothelioma), brain tumors (i.e. astrocytoma & glioblastoma multiforme), many other malignant tumors, intractable pain including fibromyalgia, & some cardio-vascular pathology: Safe & effective methods of reducing asbestos from normal & pathological areas. Acupunct Electrother Res; 2006;31(1-2):61-125
Hazardous Substances Data Bank. ASBESTOS .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Asbestos as a possible major cause of malignant lung tumors (including small cell carcinoma, adenocarcinoma & mesothelioma), brain tumors (i.e. astrocytoma & glioblastoma multiforme), many other malignant tumors, intractable pain including fibromyalgia, & some cardio-vascular pathology: Safe & effective methods of reducing asbestos from normal & pathological areas.
  • High incidences of Small Cell Carcinoma & Adenocarcinoma of the lung, Astrocytoma & Glioblastoma Multiforme of the brain and Mesothelioma of the lung were found in those who had a high accumulation of Asbestos in the eyes and upper respiratory system (nose, larynx, trachea, etc.).
  • Relatively high levels of Asbestos (0.2 approximately 0.6 mg BDORT units) were found in: Squamous Cell Carcinoma of the lungs & esophagus, Adenocarcinoma of the larynx & breast, myelogenic leukemia, arteries of these cancers, left ventricle of failing heart, myocardial infarction, some of the narrowed arteries, varicose veins, cataracts, balding heads, hot flashes, Alzheimer's Disease and Autism.


11. Nistal M, Yébenes-Gregorio L, Esteban-Rodríguez I, Bernáldez R, Regadera J: Malignant mixed tumor of the larynx. Head Neck; 2005 Feb;27(2):166-70

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant mixed tumor of the larynx.
  • BACKGROUND: Malignant mixed tumor of the larynx is a very rare neoplasm; only five cases have been reported, three in the English-language literature.
  • The tumor involved the glottic and subglottic regions and thyroid cartilage and extended to the anterior side of the larynx.
  • The epithelial cells resembled a moderately differentiated adenocarcinoma, the mesenchymal cells resembled a high-grade chondrosarcoma, and the spindle cells had immunohistochemical features of myoepithelial cells.
  • Differences between this tumor and that of laryngeal chondrosarcoma are discussed.
  • [MeSH-major] Laryngeal Neoplasms / pathology. Mixed Tumor, Malignant / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2005 Wiley Periodicals, Inc.
  • (PMID = 15641103.001).
  • [ISSN] 1043-3074
  • [Journal-full-title] Head & neck
  • [ISO-abbreviation] Head Neck
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


12. Zeng Q, Tang PZ, Xu ZG, Qi YF, Wu XX, Liu WS: [Malignant minor salivary gland tumors of the larynx]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan;44(1):40-3
MedlinePlus Health Information. consumer health - Salivary Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Malignant minor salivary gland tumors of the larynx].
  • OBJECTIVE: To study the clinical features, treatment and prognosis of malignant minor salivary gland tumors of the larynx.
  • METHODS: Treatment and outcome were retrospectively analyzed in a consecutive series of 15 patients with malignant minor salivary gland tumors of the larynx treated in this hospital from 1959 to 2005.
  • Ten patients (66.7%) had adenoid cystic carcinoma and 2 (13.3%) had adenocarcinoma.
  • The other three patients had mucoepidermoid carcinomas, polymorphic adenocarcinoma and base cell carcinoma respectively.
  • CONCLUSIONS: Minor salivary gland carcinomas of the larynx are rare and they are prone to the local recurrence and the distant metastasis in advanced stage.
  • [MeSH-major] Laryngeal Neoplasms / therapy. Salivary Gland Neoplasms / therapy. Salivary Glands, Minor / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19484987.001).
  • [ISSN] 1673-0860
  • [Journal-full-title] Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
  • [ISO-abbreviation] Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


13. Mvouni S, Tombu S, Meurisse M, Moreau P: Management of an insular thyroid carcinoma invading the larynx and trachea. B-ENT; 2006;2(1):17-20
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of an insular thyroid carcinoma invading the larynx and trachea.
  • Management of an insular thyroid carcinoma invading the larynx and trachea.
  • We report the case of an insular carcinoma invading the larynx and trachea, which was treated by total laryngectomy, bilateral neck dissection and external beam irradiation.
  • [MeSH-major] Adenocarcinoma, Follicular / pathology. Larynx / pathology. Thyroid Neoplasms / pathology. Trachea / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16676842.001).
  • [ISSN] 1781-782X
  • [Journal-full-title] B-ENT
  • [ISO-abbreviation] B-ENT
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


14. González-García R, Rodríguez-Campo FJ, Muñoz-Guerra MF, Nam-Cha SH, Sastre-Pérez J, Naval-Gías L: Polymorphous low-grade adenocarcinoma of the palate: report of cases. Auris Nasus Larynx; 2005 Sep;32(3):275-80
Genetic Alliance. consumer health - Polymorphous low-grade adenocarcinoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Polymorphous low-grade adenocarcinoma of the palate: report of cases.
  • OBJECTIVE: Polymorphous low-grade adenocarcinoma (PLGA) is a rare tumor that mostly affects minor salivary glands.
  • [MeSH-major] Adenocarcinoma / diagnosis. Palatal Neoplasms / diagnosis
  • [MeSH-minor] Adult. Aged. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Immunohistochemistry. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Recurrence, Local / pathology. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15963668.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 30
  •  go-up   go-down


15. Barbeaux A, Duck L, Weynand B, Desuter G, Hamoir M, Gregoire V, Baurain JF, Machiels JP: Primary combined squamous and small cell carcinoma of the larynx: Report of two cases and discussion of treatment modalities. Eur Arch Otorhinolaryngol; 2006 Aug;263(8):786-90
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary combined squamous and small cell carcinoma of the larynx: Report of two cases and discussion of treatment modalities.
  • Combined small cell carcinoma (SMCC) of the larynx consists of SMCC admixed with a component of squamous cell carcinoma or adenocarcinoma.
  • Here, we describe two additional cases of combined SMCC of the larynx that illustrate the difficulties that we can encounter to diagnose correctly these patients and, by consequence, to treat them adequately.
  • [MeSH-major] Carcinoma, Small Cell / therapy. Carcinoma, Squamous Cell / therapy. Laryngeal Neoplasms / therapy

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16718502.001).
  • [ISSN] 0937-4477
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 24
  •  go-up   go-down


16. Dib N, Benhammou A, Meziane M, Harmouch A, Nazih N, Essakali L, Kzadri M, Sefiani S: [Papillary adenocarcinoma on ectopic thyroid tissue]. Ann Otolaryngol Chir Cervicofac; 2009 Apr;126(2):65-70

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Papillary adenocarcinoma on ectopic thyroid tissue].
  • OBJECTIVES: To report a case of papillary adenocarcinoma occurring on ectopic thyroid tissue in the hyoid bone region.
  • Cervical MRI provided a more precise assessment of the extension of the mass and confirmed the integrity of the other structures, in particular the endo-larynx.
  • The pathologic study suggested a papillary adenocarcinoma on ectopic thyroid tissue.
  • CONCLUSIONS: Papillary adenocarcinoma on ectopic thyroid is a very rare situation.
  • Its diagnosis is histological.
  • [MeSH-major] Adenocarcinoma, Papillary / pathology. Choristoma / pathology. Hyoid Bone / pathology. Thyroid Gland. Tongue Neoplasms / pathology
  • [MeSH-minor] Diagnosis, Differential. Humans. Male. Middle Aged. Thyroidectomy. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19296927.001).
  • [ISSN] 0003-438X
  • [Journal-full-title] Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Société d'oto-laryngologie des hôpitaux de Paris
  • [ISO-abbreviation] Ann Otolaryngol Chir Cervicofac
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


17. Kariya S, Kosaka M, Orita Y, Akagi H, Nishizaki K: Adenocarcinoma ex pleomorphic adenoma of the head and neck: Report of five cases. Auris Nasus Larynx; 2006 Mar;33(1):43-6
Hazardous Substances Data Bank. FLUOROURACIL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenocarcinoma ex pleomorphic adenoma of the head and neck: Report of five cases.
  • OBJECTIVE: Adenocarcinoma ex pleomorphic adenoma is a rare tumor, and thus the management of the tumor has not been established.
  • RESULTS: We present five cases of adenocarcinoma ex pleomorphic adenoma of the head and neck, including a rare case with nasopharyngeal adenocarcinoma ex pleomorphic adenoma.
  • There was no response to chemotherapy with nedaplatin and 5-FU, but the nasopharyngeal adenocarcinoma ex pleomorphic adenoma showed a remarkable regression after the administration of docetaxel.
  • CONCLUSION: The combination therapy that includes docetaxel may be a promising treatment for adenocarcinoma ex pleomorphic adenoma of the head and neck.

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • Hazardous Substances Data Bank. DOCETAXEL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16168590.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Organoplatinum Compounds; 0 / Taxoids; 15H5577CQD / docetaxel; 8UQ3W6JXAN / nedaplatin; U3P01618RT / Fluorouracil
  •  go-up   go-down


18. Fu CH, Chang KP, Ueng SH, Wu CC, Hao SP: Primary thyroid-like papillary adenocarcinoma of the nasopharynx. Auris Nasus Larynx; 2008 Dec;35(4):579-82
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary thyroid-like papillary adenocarcinoma of the nasopharynx.
  • Thyroid-like papillary adenocarcinoma is an extremely rare neoplasm in the nasopharynx.
  • We present a case with a pedunculated tumor in the nasopharyngeal vault and the preoperative biopsy revealed a thyroid-like papillary adenocarcinoma.
  • Postoperative histopathological examinations and immunohistochemical studies confirmed the diagnosis.
  • [MeSH-major] Adenocarcinoma, Papillary / diagnosis. Nasopharyngeal Neoplasms / diagnosis
  • [MeSH-minor] Aged. Biopsy. Diagnosis, Differential. Endoscopy. Humans. Male. Nasopharynx / pathology. Thyroid Neoplasms / diagnosis. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18201851.001).
  • [ISSN] 1879-1476
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


19. Shine NP, O'Sullivan P: Collet-Sicard syndrome: a rare presentation of metastatic prostate adenocarcinoma. Auris Nasus Larynx; 2005 Sep;32(3):315-8
MedlinePlus Health Information. consumer health - Prostate Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Collet-Sicard syndrome: a rare presentation of metastatic prostate adenocarcinoma.
  • Metastatic spread of prostate adenocarcinoma to the temporal bone is rare.
  • A case of metastatic prostate adenocarcinoma involving the temporal bone causing a Collet-Sicard syndrome associated with an ipsilateral lower motor facial palsy and a mixed sensorineural and conductive hearing loss is presented.
  • This case highlights the potential of prostate adenocarcinoma to cause symptoms referable to the temporal bone region and histopathologic analysis of biopsy material should include immunohistochemical staining for prostate specific antigen.
  • [MeSH-major] Adenocarcinoma / secondary. Cranial Nerve Diseases / etiology. Prostatic Neoplasms / pathology. Skull Neoplasms / secondary. Temporal Bone

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15885949.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


20. Prasanna R, Harish CC, Pichai R, Sakthisekaran D, Gunasekaran P: Anti-cancer effect of Cassia auriculata leaf extract in vitro through cell cycle arrest and induction of apoptosis in human breast and larynx cancer cell lines. Cell Biol Int; 2009 Feb;33(2):127-34
Genetic Alliance. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anti-cancer effect of Cassia auriculata leaf extract in vitro through cell cycle arrest and induction of apoptosis in human breast and larynx cancer cell lines.
  • The in vitro anti-cancer effect of Cassia auriculata leaf extract (CALE) was evaluated in human breast adenocarcinoma MCF-7 and human larynx carcinoma Hep-2 cell lines.
  • [MeSH-minor] Breast Neoplasms / metabolism. Cell Line, Tumor. Humans. Inhibitory Concentration 50. Laryngeal Neoplasms / metabolism. Plant Leaves / chemistry. Proto-Oncogene Proteins c-bcl-2 / metabolism. bcl-2-Associated X Protein / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18996213.001).
  • [ISSN] 1095-8355
  • [Journal-full-title] Cell biology international
  • [ISO-abbreviation] Cell Biol. Int.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / Plant Extracts; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / bcl-2-Associated X Protein
  •  go-up   go-down


21. Nagano H, Yoshifuku K, Deguchi K, Kurono Y: Adenocarcinoma of the paranasal sinuses and nasal cavity with lung metastasis showing complete response to combination chemotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF): a case report. Auris Nasus Larynx; 2010 Apr;37(2):238-43
Hazardous Substances Data Bank. FLUOROURACIL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenocarcinoma of the paranasal sinuses and nasal cavity with lung metastasis showing complete response to combination chemotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF): a case report.
  • Adenocarcinoma developing in paranasal sinuses and nasal cavity generally has a low response to radiotherapy and low chemotherapeutic sensitivity, making surgery the most reliable treatment.
  • However, advanced adenocarcinoma is often difficult to treat due to anatomical complexity, and the outcome may not be satisfactory.
  • Adenocarcinoma was diagnosed by open biopsy.
  • The patient is alive after a follow-up period of 43 months, indicating that TPF chemotherapy may be useful for adenocarcinoma of the paranasal sinuses and nasal cavity.
  • [MeSH-major] Adenocarcinoma / secondary. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Lung Neoplasms / drug therapy. Lung Neoplasms / secondary. Nose Neoplasms / drug therapy. Paranasal Sinus Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • Hazardous Substances Data Bank. DOCETAXEL .
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 19560300.001).
  • [ISSN] 1879-1476
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Taxoids; 15H5577CQD / docetaxel; Q20Q21Q62J / Cisplatin; U3P01618RT / Fluorouracil
  •  go-up   go-down


22. Veit JA, Reichelt U, Tesche S: Signet ring cell adenocarcinoma of the oropharynx: presentation of a rare case and review of the literature. Auris Nasus Larynx; 2009 Dec;36(6):717-20
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Signet ring cell adenocarcinoma of the oropharynx: presentation of a rare case and review of the literature.
  • [MeSH-major] Carcinoma, Signet Ring Cell / diagnosis. Oropharyngeal Neoplasms / diagnosis
  • [MeSH-minor] Aged, 80 and over. Biopsy. Diagnosis, Differential. Female. Humans. Laser Therapy. Lymph Nodes / pathology. Magnetic Resonance Imaging. Neck Dissection. Neoplasm Staging. Oropharynx / pathology. Oropharynx / surgery. Radiotherapy, Adjuvant. Tracheostomy

  • The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for signet ring cell adenocarcinoma .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19446973.001).
  • [ISSN] 1879-1476
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 15
  •  go-up   go-down


23. Martínez JG, Pérez-Escuredo J, López F, Suárez C, Alvarez-Marcos C, Llorente JL, Hermsen MA: Microsatellite instability analysis of sinonasal carcinomas. Otolaryngol Head Neck Surg; 2009 Jan;140(1):55-60
MedlinePlus Health Information. consumer health - Nasal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: Intestinal-type sinonasal adenocarcinoma (ITAC) and squamous cell carcinoma of the nasal cavity (SCCNC) are histopathologically but not etiologically similar to colorectal adenocarcinoma or to laryngeal squamous cell carcinoma, respectively.
  • CONCLUSION: MSI may be involved in squamous cell carcinoma, but not in adenocarcinoma of the nasal cavities.
  • [MeSH-major] Adenocarcinoma / genetics. Carcinoma, Squamous Cell / genetics. Microsatellite Instability. Nose Neoplasms / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19130962.001).
  • [ISSN] 0194-5998
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


24. Gao X, Dai Y, Qian X, Chen J, Chen F: [Thyroid malignant tumor with flare up glottic paralysis for first symptom]. Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Jul;20(13):608-10
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To approach clinical feature of thyroid malignant tumor with Flare up glottic paralysis for first symptom, and analysis that should be avoided missed diagnosis and misdiagnosis during diagnosis and treatment.
  • METHOD: Retrospective research five cases of thyroid malignant tumor with flare up glottic paralysis papillary adenocarcinoma of thyroid by pathology.
  • Four cases had one side glottic paralysis, the same side thyroid were moved after dissecting the recurrent laryngeal nerve.
  • The last one had right gliotic paralysis first, then both cricoarytenoid joint had been fixed, hoarse voice was worse and developed to dyspnea since the tumor invaded in larynx one year later.
  • We only did cut the right thyroid and right half larynx, but the tumor came back again in larynx in three months, then had to removal whole larynx without recurrence follow up two years.
  • CONCLUSION: For the flare up glottic paralysis with same side tiny thyroid tumor, we suggest that the thyroid must be made operation research if no other reasons, dissecting and protecting the recurrent laryngeal nerve during operation, and cut reasonable thyroid and others according to fast pathologic diagnosis.
  • [MeSH-major] Carcinoma, Papillary / diagnosis. Thyroid Neoplasms / diagnosis. Vocal Cord Paralysis / diagnosis
  • [MeSH-minor] Humans. Laryngeal Nerves / surgery. Larynx / surgery. Male. Middle Aged. Retrospective Studies

  • Genetic Alliance. consumer health - paralysis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16981475.001).
  • [Journal-full-title] Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology
  • [ISO-abbreviation] Lin Chuang Er Bi Yan Hou Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


25. Xue LY, Zou SM, Zheng S, Xie YQ, Wen P, Liu XY, Lin DM, Lü N: [Expression of fascin and CK14 in different histological types of cancer and its differential diagnostic significance]. Zhonghua Zhong Liu Za Zhi; 2010 Nov;32(11):838-44
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To investigate and analyze the expression of fascin and CK14 in multiple histological types of cancer and to explore the potential value of the two proteins as markers in diagnosis and differential diagnosis of various cancer types.
  • METHODS: Tissue microarray containing esophageal squamous cell carcinoma (SCC), lung SCC, larynx SCC, uterine cervical SCC, SCC of external genital organs, lung adenocarcinoma, gastric adenocarcinoma, colorectal adenocarcinoma, heptocellular carcinoma, pancreatic ductal adenocarcinoma, breast infiltrating ductal carcinoma, thyroid papillary carcinoma, uterine endometrioid adenocarcinoma, ovarian serous adenocarcinoma and renal clear cell carcinoma, 30 cases each, as well as corresponding normal controls was constructed.
  • RESULTS: In normal esophagus, bronchus, larynx, uterine cervix and skin, fascin was mainly expressed in the basal cells or reserve cells, but the expression was diffuse in esophageal SCC, lung SCC, larynx SCC, uterine cervical SCC and SCC of external genital organs, with a positive rate of 90.0%, 90.0%, 96.7%, 78.6% and 89.7%, respectively.
  • In lung adenocarcinoma, gastric adenocarcinoma, colorectal adenocarcinoma, hepatocellular carcinoma, pancreatic ductal adenocarcinoma, breast infiltrating dutal adenocarcinoma, thyroid papillary carcinoma, uterine endometrioid adenocarcinoma, ovarian serous adenocarcinoma and renal clear cell carcinoma, the positive rates were 38.0%, 23.3%, 14.3%, 10.3%, 73.3%, 13.3%, 6.7%, 60.0%, 66.7% and 10.0%, respectively.
  • The positive rates of CK14 were 76.7%, 36.7%, 83.3%, 60.7% and 96.3% in esophageal SCC, lung SCC, larynx SCC, uterine cervical SCC and SCC of external genital organs, respectively.
  • It was weak and focal in lung adenocarcinoma, gastric adenocarcinoma, colorectal adenocarcinoma, hepatocellular carcinoma, pancreatic ductal adenocarcinoma, breast infiltrating dutal adenocarcinoma, thyroid papillary carcinoma, uterine endometrioid adenocarcinoma, ovarian serous adenocarcinoma, and renal clear cell carcinoma, with a positive rate of 13.3%, 13.3%, 20.7%, 41.4%, 46.7%, 6.7%, 40.0%, 13.3%, 20.0% and 6.7%, respectively.
  • Combination of fascin and CK14 should be a valuable marker in diagnosis and differential diagnosis of carcinoma.
  • [MeSH-major] Adenocarcinoma / metabolism. Carcinoma, Squamous Cell / metabolism. Carrier Proteins / metabolism. Keratin-14 / metabolism. Laryngeal Neoplasms / metabolism. Microfilament Proteins / metabolism
  • [MeSH-minor] Breast Neoplasms / metabolism. Breast Neoplasms / pathology. Carcinoma, Hepatocellular / metabolism. Carcinoma, Hepatocellular / pathology. Colorectal Neoplasms / metabolism. Colorectal Neoplasms / pathology. Cystadenocarcinoma, Serous / metabolism. Cystadenocarcinoma, Serous / pathology. Diagnosis, Differential. Esophageal Neoplasms / metabolism. Esophageal Neoplasms / pathology. Female. Humans. Liver Neoplasms / metabolism. Liver Neoplasms / pathology. Lung Neoplasms / metabolism. Lung Neoplasms / pathology. Male. Ovarian Neoplasms / metabolism. Ovarian Neoplasms / pathology. Stomach Neoplasms / metabolism. Stomach Neoplasms / pathology. Uterine Cervical Neoplasms / metabolism. Uterine Cervical Neoplasms / pathology

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21223690.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Carrier Proteins; 0 / Keratin-14; 0 / Microfilament Proteins; 146808-54-0 / fascin
  •  go-up   go-down


26. Schuler PJ, Heikaus S, Friebe-Hoffmann U, Hoffmann TK, Greve J, Klenzner T, Schipper J, Scheckenbach K: [Breast cancer metastases in the head and neck region]. HNO; 2010 Aug;58(8):859-65
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Breast cancer metastases to the head and neck region are very rare and therefore represent a challenge for the clinician in terms of diagnosis and therapy.
  • Here we present the cases of two breast cancer patients who developed filiae into the petrous portion of the temporal bone and one very rare case of metastasis to the larynx.
  • Diagnosis, therapy and distinctive features of metastasis to the head and neck region are discussed.Secondary to long-term endocrine hormone therapy, a reduction in estrogen receptor expression occurred in all three cases.
  • Moreover, this receptor loss hindered the pathologist from confirming the diagnosis of metastases at very unusual sites.
  • [MeSH-major] Breast Neoplasms / diagnosis. Carcinoma, Ductal / secondary. Laryngeal Neoplasms / secondary. Petrous Bone. Skull Neoplasms / secondary
  • [MeSH-minor] Adenocarcinoma, Mucinous / diagnosis. Adenocarcinoma, Mucinous / pathology. Adenocarcinoma, Mucinous / therapy. Aged. Combined Modality Therapy. Diagnosis, Differential. Female. Humans. Larynx / pathology. Magnetic Resonance Imaging. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Neoplasms, Second Primary / diagnosis. Neoplasms, Second Primary / pathology. Neoplasms, Second Primary / therapy. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20596682.001).
  • [ISSN] 1433-0458
  • [Journal-full-title] HNO
  • [ISO-abbreviation] HNO
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


27. Xue LY, Teng LH, Zou SM, Ren LQ, Zheng S, Luo W, Bi R, Lü N: [Expression of annexin I in different histological types of carcinomas]. Zhonghua Zhong Liu Za Zhi; 2007 Jun;29(6):444-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: First, a set of tissue microarray was established, which consisted of SCC from the esophagus (208 cases), lung, larynx, cervix, and external genital organs; adenocarcinomas from the lung, stomach, colon and rectum, liver, pancreas, breast, thyroid and kidney with 30 cases in each group, meanwhile, the corresponding normal tissue was also obtained for control.
  • RESULTS: It was found that the expression of annexin I was decreased in esophageal SCC, when compared with normal esophageal squamous epithelia (P < 0.001), the similarity was also found in SCC of the lung, larynx and cervix.
  • Annexin I was found to be overexpressed in adenocarcinomas of the lung, stomach, colon and rectum, liver, pancreas, breast, thyroid and kidney, particularly very strong expression of annexin I was seen in lung adenocarcinoma, uterine endometrioid adenocarcinoma and ovarian serous adenocarcinoma.
  • However, annexin I expression was found to be negative in all hepatocellular carcinoma and normal hepatocytes; and it was only detected in myoepithelium of normal breast tissue, but not in ductal luminal cells, and rarely in infiltrating ductal adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / metabolism. Annexin A1 / metabolism. Carcinoma, Squamous Cell / metabolism. Esophageal Neoplasms / metabolism. Lung Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17974280.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Annexin A1
  •  go-up   go-down


28. Rooney S, Ryan MF: Effects of alpha-hederin and thymoquinone, constituents of Nigella sativa, on human cancer cell lines. Anticancer Res; 2005 May-Jun;25(3B):2199-204
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The separate effects of alpha-hederin and thymoquinone, the two principal bioactive constituents of Nigella sativa, on four human cancer cell lines [A549 (lung carcinoma), HEp-2 (larynx epidermoid carcinoma), HT-29 (colon adenocarcinoma) and MIA PaCa-2 (pancreas carcinoma)] were investigated.
  • [MeSH-minor] Adenocarcinoma / drug therapy. Apoptosis / drug effects. Cell Line, Tumor. Colonic Neoplasms / drug therapy. Dose-Response Relationship, Drug. Drug Screening Assays, Antitumor. HT29 Cells. Humans. Inhibitory Concentration 50. Laryngeal Neoplasms / drug therapy. Lung Neoplasms / drug therapy. Necrosis. Nigella sativa / chemistry. Pancreatic Neoplasms / drug therapy. Prodrugs / pharmacology

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16158964.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Benzoquinones; 0 / Drugs, Chinese Herbal; 0 / Prodrugs; 0 / Saponins; 27013-91-8 / alpha-hederin; 490-91-5 / thymoquinone; 6SMK8R7TGJ / Oleanolic Acid
  •  go-up   go-down


29. Takemura T, Ogata N, Yumoto E: [Clinical analysis of cervical metastatis from an unknown primary carcinoma]. Nihon Jibiinkoka Gakkai Kaiho; 2005 Oct;108(10):996-1003
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • With respect to the histopathological types, 16 cases had squamous cell carcinoma, 2 cases had adenocarcinoma and 1 case had ductal carcinoma.
  • The presence of primary lesions was comfirmed in 11 cases (3 tonsil, 1 nasopharynx, 1 base of tongue, 2 hypopharynx, 1 esophagus, 1 larynx, 1 gallduct, 1 mammary gland) after the treatment of their metastatic leisions.
  • [MeSH-major] Adenocarcinoma / secondary. Carcinoma, Ductal / secondary. Carcinoma, Squamous Cell / secondary. Head and Neck Neoplasms / secondary. Neoplasms, Unknown Primary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16285615.001).
  • [ISSN] 0030-6622
  • [Journal-full-title] Nihon Jibiinkoka Gakkai kaiho
  • [ISO-abbreviation] Nippon Jibiinkoka Gakkai Kaiho
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


30. Vellin JF, Achim V, Sinardet D, Gabrillargues J, Mom T, Gilain L: Rapidly developing leptomeningeal carcinomatosis following anterior skull base surgery: a case report. Auris Nasus Larynx; 2007 Dec;34(4):565-7
MedlinePlus Health Information. consumer health - After Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report an atypical rapid post-operative leptomeningeal carcinomatosis after skull base resection for an ethmoidal adenocarcinoma.
  • A strong index of suspicion along with clinical and radiological correlation is essential to arrive at a correct diagnosis.
  • [MeSH-major] Adenocarcinoma, Mucinous / secondary. Adenocarcinoma, Mucinous / surgery. Cranial Fossa, Anterior / surgery. Ethmoid Sinus / surgery. Meningeal Neoplasms / secondary. Neoplasm Seeding. Paranasal Sinus Neoplasms / surgery. Postoperative Complications / etiology. Skull Base Neoplasms / surgery
  • [MeSH-minor] Aged. Cranial Nerve Neoplasms / diagnosis. Cranial Nerve Neoplasms / secondary. Disease Progression. Fatal Outcome. Humans. Magnetic Resonance Imaging. Male. Neoplasm, Residual / diagnosis. Neoplasm, Residual / etiology. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17507192.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


31. Mizutari K, Naganishi H, Tanaka Y: Oncocytic carcinoma in the submandibular gland: report of a case based on anti-mitochondrial immunohistochemical observations. Auris Nasus Larynx; 2005 Sep;32(3):305-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Immunohistochemistry using an anti-mitochondrial antibody was found to be useful and helpful for the diagnosis of oncocytic lesions.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / pathology. Immunohistochemistry / methods. Mitochondria / immunology. Submandibular Gland Neoplasms / diagnosis. Submandibular Gland Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15869853.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antibodies
  •  go-up   go-down


32. Fruscalzo A, Damante G, Calcagno A, Di Loreto C, Marchesoni D: Four primary malignancies successively occurred in a BRCA2 mutation carrier: a case report. Cancer Invest; 2006 Oct;24(6):611-4
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Several other carcinomas seem to be associated with BRCA2 mutations: pancreas, prostate, larynx, gallbladder, bile duct cancer, and malignant melanoma.
  • We described a case of a 67-year-old BRCA2 mutation carrier of Caucasian, non-Jewish, ethnic origin who successively developed 4 primary malignancies in 30 months: breast ductal carcinoma, chronic lymphatic leukemia, ovarian serous papillary carcinoma, and endocervical adenocarcinoma.
  • Chronic lymphatic leukemia and endocervical adenocarcinoma have not been yet associated to BRCA2 germline mutation.
  • [MeSH-minor] Adenocarcinoma / genetics. Adenocarcinoma / pathology. Adenocarcinoma / therapy. Adult. Aged. Carcinoma, Ductal, Breast / genetics. Carcinoma, Ductal, Breast / pathology. Carcinoma, Ductal, Breast / therapy. Cystadenocarcinoma, Papillary / genetics. Cystadenocarcinoma, Papillary / pathology. Cystadenocarcinoma, Papillary / therapy. Cystadenocarcinoma, Serous / genetics. Cystadenocarcinoma, Serous / pathology. Cystadenocarcinoma, Serous / therapy. Female. Genetic Predisposition to Disease. Humans. Male. Middle Aged. Pedigree

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16982466.001).
  • [ISSN] 0735-7907
  • [Journal-full-title] Cancer investigation
  • [ISO-abbreviation] Cancer Invest.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / BRCA2 Protein
  •  go-up   go-down


33. Villaret AB, Piazza C, Peretti G, Calabrese L, Ansarin M, Chiesa F, Pellini R, Spriano G, Nicolai P: Multicentric prospective study on the prevalence of sublevel IIb metastases in head and neck cancer. Arch Otolaryngol Head Neck Surg; 2007 Sep;133(9):897-903

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Primary site distribution included the following: oral cavity in 111 patients, larynx in 92, oropharynx in 32, thyroid gland in 22, skin of the lateral face or scalp in 16, hypopharynx in 11, unknown primary in 7, and parotid gland in 6.
  • Tumor histologic type in the sublevel IIB+ population was squamous cell carcinoma in 80%, papillary carcinoma in 8%, melanoma in 8%, and adenocarcinoma in 4%.
  • Patients affected by laryngeal cancer scheduled for elective ND can be considered the ideal candidates for preservation of sublevel IIB.
  • [MeSH-minor] Adenocarcinoma / epidemiology. Adenocarcinoma / pathology. Adenocarcinoma / surgery. Adolescent. Adult. Aged. Aged, 80 and over. Carcinoma, Papillary / epidemiology. Carcinoma, Papillary / pathology. Carcinoma, Papillary / surgery. Carcinoma, Squamous Cell / epidemiology. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / surgery. Cross-Sectional Studies. Female. Humans. Lymph Node Excision. Male. Melanoma / epidemiology. Melanoma / pathology. Melanoma / surgery. Middle Aged. Neoplasm Staging. Prognosis. Prospective Studies. Skin Neoplasms / epidemiology. Skin Neoplasms / pathology. Skin Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17875856.001).
  • [ISSN] 0886-4470
  • [Journal-full-title] Archives of otolaryngology--head & neck surgery
  • [ISO-abbreviation] Arch. Otolaryngol. Head Neck Surg.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] United States
  •  go-up   go-down


34. Suzuki T, Sakaguchi H, Yamamoto S, Hisa Y: Sudden hearing loss due to meningeal carcinomatosis from rectal carcinoma. Auris Nasus Larynx; 2006 Sep;33(3):315-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We present a case of meningeal carcinomatosis with bilateral hearing loss secondary to a rectal adenocarcinoma.
  • A 60-year-old woman developed progressive loss of hearing in the left ear 19 months after an abdominoperineal resection for an adenocarcinoma of the rectum.
  • [MeSH-major] Adenocarcinoma / secondary. Ear Neoplasms / complications. Hearing Loss, Sensorineural / etiology. Hearing Loss, Sudden / etiology. Meningeal Neoplasms / secondary. Rectal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16413982.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


35. Kumamoto M, Kuratomi Y, Yasumatsu R, Nakashima T, Masuda M, Inokuchi A: Expression of laminin 5 basement membrane components in invading and recurring adenoid cystic carcinoma of the head and neck. Auris Nasus Larynx; 2006 Jun;33(2):167-72
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma / genetics. Adenocarcinoma / metabolism. Adenocarcinoma / pathology. Adult. Aged. Antibodies, Monoclonal / metabolism. Basement Membrane / metabolism. Basement Membrane / pathology. Collagen Type IV / metabolism. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16332421.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Collagen Type IV; 0 / LAMC2 protein, human; 0 / Laminin
  •  go-up   go-down


36. Mebed AH: Aggressive surgical therapy for locally invasive differentiated thyroid carcinoma : an experience of nineteen ( 19 ) cases. J Egypt Natl Canc Inst; 2007 Dec;19(4):282-91
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The median age at diagnosis was 54 years.
  • This treatment protocol is suitable in tumors with surface invasion of the upper aeorodigestive tract and those invading the recurrent laryngeal nerve.
  • [MeSH-minor] Adenocarcinoma, Follicular / pathology. Adenocarcinoma, Follicular / surgery. Adult. Aged. Carcinoma, Papillary / pathology. Carcinoma, Papillary / surgery. Esophagus / pathology. Esophagus / surgery. Female. Humans. Larynx / pathology. Larynx / surgery. Male. Middle Aged. Neck Dissection. Neoplasm Invasiveness. Pharynx / pathology. Pharynx / surgery. Postoperative Complications. Skin / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19652671.001).
  • [ISSN] 1110-0362
  • [Journal-full-title] Journal of the Egyptian National Cancer Institute
  • [ISO-abbreviation] J Egypt Natl Canc Inst
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Egypt
  •  go-up   go-down


37. Favia G, Iacobone M, Zanella S, Ciarleglio FA: Management of invasive and advanced thyroid cancer. Minerva Endocrinol; 2009 Mar;34(1):37-55
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma, Follicular / pathology. Adenocarcinoma, Follicular / secondary. Adenocarcinoma, Follicular / therapy. Adenoma, Oxyphilic / surgery. Carcinoma / radiotherapy. Carcinoma / secondary. Carcinoma / surgery. Carcinoma, Medullary / surgery. Carcinoma, Papillary / pathology. Carcinoma, Papillary / secondary. Carcinoma, Papillary / therapy. Child. Combined Modality Therapy. Female. Humans. Iodine Radioisotopes / therapeutic use. Larynx / pathology. Lymphatic Metastasis. Neck Muscles / pathology. Neoplasm Invasiveness. Neoplasm Staging. Palliative Care. Prognosis. Recurrent Laryngeal Nerve / pathology. Thyroidectomy. Trachea / pathology

  • Genetic Alliance. consumer health - Thyroid Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19209127.001).
  • [ISSN] 0391-1977
  • [Journal-full-title] Minerva endocrinologica
  • [ISO-abbreviation] Minerva Endocrinol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Iodine Radioisotopes
  • [Number-of-references] 174
  •  go-up   go-down


38. Tsukahara K, Kawabata K, Mitani H, Yoshimoto S, Sugitani I, Yonekawa H, Beppu T, Fukushima H, Sasaki T: Three cases of bilateral chylothorax developing after neck dissection. Auris Nasus Larynx; 2007 Dec;34(4):573-6
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Diagnosis may be delayed in those who are on total parenteral nutrition, and therefore particular attention should be paid to those patients.
  • [MeSH-major] Adenocarcinoma, Papillary / surgery. Chylothorax / etiology. Laryngeal Neoplasms / surgery. Neck Dissection / adverse effects. Postoperative Complications / etiology. Thyroid Neoplasms / surgery. Tongue Neoplasms / surgery
  • [MeSH-minor] Aged. Diagnosis, Differential. Female. Humans. Ligation. Male. Middle Aged. Neoplasm Staging. Parenteral Nutrition, Total. Thoracic Duct / surgery. Thoracostomy

  • MedlinePlus Health Information. consumer health - After Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17466474.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 20
  •  go-up   go-down


39. Culhaci N, Sagol O, Karademir S, Astarcioglu H, Astarcioglu I, Soyturk M, Oztop I, Obuz F: Expression of transforming growth factor-beta-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics. BMC Cancer; 2005;5:98
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: We examined TGF-beta1 and p27 expression immunohistochemically in 63 cases of invasive ductal adenocarcinoma of the pancreas.
  • [MeSH-major] Adenocarcinoma / metabolism. Cyclin-Dependent Kinase Inhibitor p27 / biosynthesis. Immunohistochemistry / methods. Pancreatic Neoplasms / metabolism. Transforming Growth Factor beta / biosynthesis

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • Hazardous Substances Data Bank. BIOTIN .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pharmacol Ther. 2003 May;98(2):257-65 [12725873.001]
  • [Cites] Am J Pathol. 1999 Oct;155(4):1129-36 [10514396.001]
  • [Cites] J Clin Gastroenterol. 2003 Jul;37(1):23-7 [12811204.001]
  • [Cites] Jpn J Clin Oncol. 2003 Jul;33(7):346-52 [12949061.001]
  • [Cites] Dig Dis Sci. 2004 May;49(5):828-32 [15259505.001]
  • [Cites] Surgery. 2004 Aug;136(2):364-74 [15300203.001]
  • [Cites] Gastroenterology. 1993 Dec;105(6):1846-56 [8253361.001]
  • [Cites] Cancer Res. 1997 Sep 15;57(18):3929-34 [9307274.001]
  • [Cites] Dig Dis Sci. 1997 Oct;42(10):2054-63 [9365135.001]
  • [Cites] J Urol. 1998 Mar;159(3):941-5 [9474188.001]
  • [Cites] Am J Clin Pathol. 1998 Jul;110(1):16-23 [9661918.001]
  • [Cites] Prostate. 1998 Sep 15;37(1):19-29 [9721065.001]
  • [Cites] Jpn J Clin Oncol. 1998 Sep;28(9):534-7 [9793024.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 1998;5(4):383-91 [9931387.001]
  • [Cites] Hum Pathol. 1999 Feb;30(2):123-9 [10029438.001]
  • [Cites] Cancer. 1999 Mar 1;85(5):1011-7 [10091782.001]
  • [Cites] Int J Cancer. 2000 Jan 1;85(1):27-34 [10585578.001]
  • [Cites] J Clin Pathol. 1999 Aug;52(8):555-68 [10645224.001]
  • [Cites] J Urol. 2000 Dec;164(6):1987-91 [11061897.001]
  • [Cites] J Urol. 2000 Dec;164(6):2156-61 [11061947.001]
  • [Cites] Teratog Carcinog Mutagen. 2001;21(1):27-44 [11135319.001]
  • [Cites] Eur J Cancer. 2001 Jan;37(2):224-33 [11166150.001]
  • [Cites] Pathol Int. 2001 Feb;51(2):94-9 [11169147.001]
  • [Cites] Hum Pathol. 2001 Jan;32(1):4-9 [11172288.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2000;7(5):489-95 [11180876.001]
  • [Cites] J Surg Res. 2001 Apr;96(2):284-8 [11266285.001]
  • [Cites] Pancreas. 2001 May;22(4):341-7 [11345133.001]
  • [Cites] Int J Cancer. 2001 Sep 20;95(5):302-6 [11494229.001]
  • [Cites] Trends Cell Biol. 2001 Nov;11(11):S44-51 [11684442.001]
  • [Cites] Clin Cancer Res. 2002 Jun;8(6):1808-15 [12060621.001]
  • [Cites] Oncogene. 2003 Jan 23;22(3):319-29 [12545153.001]
  • [Cites] J Oral Pathol Med. 2003 Mar;32(3):139-45 [12581383.001]
  • [Cites] J Hepatol. 2003 May;38(5):591-7 [12713869.001]
  • [Cites] Cancer. 1999 Mar 15;85(6):1250-60 [10189129.001]
  • [Cites] Am J Surg. 1999 Mar;177(3):209-15 [10219856.001]
  • [Cites] Eur J Surg. 1999 Apr;165(4):292-306 [10365829.001]
  • [Cites] Am J Surg Pathol. 1999 Jun;23(6):678-85 [10366150.001]
  • [Cites] Auris Nasus Larynx. 2003 May;30(2):163-8 [12753988.001]
  • (PMID = 16086840.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / TGFB1 protein, human; 0 / Transforming Growth Factor beta; 0 / Transforming Growth Factor beta1; 147604-94-2 / Cyclin-Dependent Kinase Inhibitor p27; 6SO6U10H04 / Biotin; 9013-20-1 / Streptavidin
  • [Other-IDs] NLM/ PMC1208869
  •  go-up   go-down


40. Ramanathan Y, Rajagopalan R, Rahman NA: Laryngeal metastasis from a rectal carcinoma. Ear Nose Throat J; 2007 Nov;86(11):685-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laryngeal metastasis from a rectal carcinoma.
  • Metastases to the larynx from distant primaries are rare.
  • We report a case of a laryngeal metastasis from a rectal carcinoma.
  • [MeSH-major] Adenocarcinoma / secondary. Laryngeal Neoplasms / secondary. Rectal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18225631.001).
  • [ISSN] 0145-5613
  • [Journal-full-title] Ear, nose, & throat journal
  • [ISO-abbreviation] Ear Nose Throat J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


41. Bień S, Kamiński B, Zyłka S, Mezyk R, Piasta Z, Markowski J, Paluch J, Kordylewska M, Wierzbicka M, Morshed K, Gryczyński M, Murlewska A, Modrzejewski M, Składzień J, Jaworowska E, Matyja G, Burduk P, Müller M, Kowalska B, Mikaszewski B, Misiołek M, Namysłowski G, Bruzgielewicz A, Osuch-Wójcikiewicz E, Szymański L, Krecicki T, Karasiewicz P, Mikulewicz W, Pietrysiak A, Jurkiewicz D, Kubik P, Janeczek T: [The evolution of epidemiology and clinical characteristics of laryngeal and hypopharyngeal carcinoma in Poland from 1991 to 2001]. Otolaryngol Pol; 2005;59(2):169-81

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The evolution of epidemiology and clinical characteristics of laryngeal and hypopharyngeal carcinoma in Poland from 1991 to 2001].
  • On the base of retrospective analysis of 12,888 cases of carcinoma of larynx and hypopharynx, diagnosed in 19 ENT Departments in Poland from 1991 to 2001, the assessment of basic epidemiological data, including the localization of tumor and stage of local and clinical advancement of the disease at the time of diagnosis has been conducted.
  • In the majority of cases the carcinoma of larynx and hypopharynx was diagnosed in the advanced stage (T3 + T4) of local disease, with the highest percentage in localization within the pyriform fossa (81.0%), and the lowest percentage in glottis tumors (45.6%).
  • The distant metastases in the analyzed group at the time of diagnosis has been registered in 2.0%, with the highest percentage in posterior pharyngeal wall (7.6%) and pyriform fossa (7.4%).
  • The authors postulate the renewal of prospective study on epidemiology, clinical characteristics and treatment results of larynx and hypopharynx carcinoma in Poland.
  • [MeSH-major] Hypopharyngeal Neoplasms / diagnosis. Hypopharyngeal Neoplasms / epidemiology. Laryngeal Neoplasms / diagnosis. Laryngeal Neoplasms / epidemiology
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adenocarcinoma / epidemiology. Adolescent. Adult. Aged. Aged, 80 and over. Carcinoma, Squamous Cell / diagnosis. Carcinoma, Squamous Cell / epidemiology. Child. Child, Preschool. Female. Humans. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Poland / epidemiology. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16095084.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


42. Arai A, Taki M, Mimaki S, Ueda M, Hori S: Low-grade cribriform cystadenocarcinoma of the parotid gland: a case report. Auris Nasus Larynx; 2009 Dec;36(6):725-8
MedlinePlus Health Information. consumer health - Tumors and Pregnancy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / diagnosis. Cystadenocarcinoma / diagnosis. Parotid Neoplasms / diagnosis. Pregnancy Complications, Neoplastic / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19477092.001).
  • [ISSN] 1879-1476
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / ACTA2 protein, human; 0 / Actins; 0 / Biomarkers, Tumor
  •  go-up   go-down


43. Urken ML: Prognosis and management of invasive well-differentiated thyroid cancer. Otolaryngol Clin North Am; 2010 Apr;43(2):301-28, viii
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This article reviews the prognosis, diagnosis, management, and implications of invasive thyroid cancer affecting the various structures of the central and lateral compartments of the neck.
  • [MeSH-major] Adenocarcinoma, Follicular / pathology. Adenocarcinoma, Follicular / surgery. Carcinoma, Papillary / pathology. Carcinoma, Papillary / surgery. Thyroid Neoplasms / pathology. Thyroid Neoplasms / surgery
  • [MeSH-minor] Disease Progression. Esophagus / pathology. Esophagus / surgery. Humans. Jugular Veins / pathology. Jugular Veins / surgery. Larynx / pathology. Larynx / surgery. Lymph Node Excision / methods. Lymphatic Metastasis / pathology. Neoplasm Invasiveness. Neoplasm Staging. Prognosis. Recurrent Laryngeal Nerve / pathology. Recurrent Laryngeal Nerve / surgery. Suture Techniques. Thyroid Gland / pathology. Trachea / pathology. Trachea / surgery

  • Genetic Alliance. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20510716.001).
  • [ISSN] 1557-8259
  • [Journal-full-title] Otolaryngologic clinics of North America
  • [ISO-abbreviation] Otolaryngol. Clin. North Am.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 43
  •  go-up   go-down


44. Glatt S, Halbauer D, Heindl S, Wernitznig A, Kozina D, Su KC, Puri C, Garin-Chesa P, Sommergruber W: hGPR87 contributes to viability of human tumor cells. Int J Cancer; 2008 May 1;122(9):2008-16
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Up-regulation of both, transcript and protein, was detected in samples of SCC of the lung, cervix, skin and head and neck (pharynx, larynx and epiglottis).
  • [MeSH-minor] Adenocarcinoma / metabolism. Apoptosis. Carcinoma, Large Cell / metabolism. Carcinoma, Transitional Cell / metabolism. Cell Line, Tumor. Cell Proliferation. Cell Survival. Female. Gene Expression Profiling. Gene Expression Regulation, Neoplastic. Head and Neck Neoplasms / metabolism. Humans. Immunoblotting. Immunohistochemistry. Lung Neoplasms / metabolism. Male. Polymerase Chain Reaction. RNA, Small Interfering / metabolism. Skin Neoplasms / metabolism. Transcription, Genetic. Up-Regulation. Urinary Bladder Neoplasms / metabolism. Uterine Cervical Neoplasms / metabolism

  • Guide to Pharmacology. gene/protein/disease-specific - GPR87 - data and references .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 Wiley-Liss, Inc.
  • (PMID = 18183596.001).
  • [ISSN] 1097-0215
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / GPR87 protein, human; 0 / RNA, Small Interfering; 0 / Receptors, Lysophosphatidic Acid
  •  go-up   go-down


45. Tsutsumi T, Nakajima N, Hirose T, Watanabe K: Total-length invasion of the facial nerve by parotid carcinoma ex pleomorphic adenoma. Auris Nasus Larynx; 2009 Oct;36(5):618-22
MedlinePlus Health Information. consumer health - Salivary Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenoma, Pleomorphic / diagnosis. Facial Nerve / pathology. Parotid Gland. Salivary Gland Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19261405.001).
  • [ISSN] 1879-1476
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


46. Cansiz H, Yener M, Bozkurt AK, Demir A, Demirkaya A, Sekercioglu N: Surgical treatment of laryngeal tumors with subglottic extension and tracheal tumors with composite nasal septal cartilage graft: technique and outcome. Auris Nasus Larynx; 2008 Sep;35(3):363-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical treatment of laryngeal tumors with subglottic extension and tracheal tumors with composite nasal septal cartilage graft: technique and outcome.
  • OBJECTIVE: Composite nasal septal cartilage grafts (CNSCG) are effective grafting materials in laryngeal and tracheal reconstruction following tumor resection.
  • METHODS: Between 1985 and 2005, we used CNSCG for the reconstruction of defects following resection of laryngeal tumors with subglottic extension (20 cases), subglottic mesenchymal tumors (2 cases), invasive thyroid carcinoma (4 cases), tracheal tumors (3 cases) and esophagus carcinoma with tracheal invasion (1 case) in total of 30 patients.
  • Overall complications consisted of subglottic stenosis in one case, and unilateral paralysis of recurrent laryngeal nerve in two cases.
  • One patient with subglottic laryngeal carcinoma died due to neck and distant metastases 4 years after the operation.
  • CONCLUSION: Free composite cartilage graft is a reliable material in the reconstruction of defects after surgery of laryngeal tumors with subglottic extension, invasive thyroid and esophagus tumors and well-selected tracheal tumors.
  • [MeSH-major] Cartilage / transplantation. Laryngeal Neoplasms / surgery. Tracheal Neoplasms / surgery
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / surgery. Adenocarcinoma, Papillary / pathology. Adenocarcinoma, Papillary / surgery. Adult. Aged. Carcinoma, Adenoid Cystic / pathology. Carcinoma, Adenoid Cystic / surgery. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / surgery. Esophageal Neoplasms / pathology. Esophageal Neoplasms / surgery. Female. Follow-Up Studies. Humans. Laryngectomy / methods. Magnetic Resonance Imaging. Male. Mesenchymoma / pathology. Mesenchymoma / surgery. Middle Aged. Neoplasm Invasiveness. Papilloma / pathology. Papilloma / surgery. Reconstructive Surgical Procedures / methods. Thyroid Neoplasms / pathology. Thyroid Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17997246.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


47. Katori H, Nozawa A, Tsukuda M: Increased expression of cyclooxygenase-2 and Ki-67 are associated with malignant transformation of pleomorphic adenoma. Auris Nasus Larynx; 2007 Mar;34(1):79-84
MedlinePlus Health Information. consumer health - Salivary Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • All Ca ex-PA showed only one malignant histological component: adenocarcinoma (23 cases), adenoid-cystic carcinoma (10), epithelial-myoepithelial carcinoma (7).
  • RESULTS: In the immunohistochemical analysis of COX-2 and Ki-67 index, significant increase was observed in Ca ex-PA, especially with adenocarcinoma, compared to pleomorphic adenoma and sialadenitis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17049779.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antibodies; 0 / Ki-67 Antigen; EC 1.14.99.1 / Cyclooxygenase 2
  •  go-up   go-down


48. Slough CM, Randolph GW: Workup of well-differentiated thyroid carcinoma. Cancer Control; 2006 Apr;13(2):99-105
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: A fiberoptic evaluation of the larynx is integral to the physical examination, and a laryngeal assessment is performed for all patients who will undergo thyroid surgery.
  • The extent of thyroidectomy is tailored not only to the patient's risk group and gross operative findings but also to the progress of the specific surgery in terms of parathyroid and recurrent laryngeal nerve preservation.
  • [MeSH-major] Adenocarcinoma, Follicular / diagnosis. Carcinoma, Papillary / diagnosis. Thyroid Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16735983.001).
  • [ISSN] 1073-2748
  • [Journal-full-title] Cancer control : journal of the Moffitt Cancer Center
  • [ISO-abbreviation] Cancer Control
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0Z5B2CJX4D / Fluorodeoxyglucose F18
  • [Number-of-references] 72
  •  go-up   go-down


49. Testa D, Galli V, de Rosa G, Iovine R, Staibano S, Somma P, Mignogna C, Iengo M: Clinical and prognostic aspects of laryngeal clear cell carcinoma. J Laryngol Otol; 2005 Dec;119(12):991-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical and prognostic aspects of laryngeal clear cell carcinoma.
  • Clear cell carcinoma (CCC) of the larynx is a rare pathological finding; only eight cases are described in the literature.
  • We report the ninth observation of laryngeal CCC in the literature.
  • [MeSH-major] Adenocarcinoma, Clear Cell / pathology. Laryngeal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16354366.001).
  • [ISSN] 0022-2151
  • [Journal-full-title] The Journal of laryngology and otology
  • [ISO-abbreviation] J Laryngol Otol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 18
  •  go-up   go-down


50. Yu WB, Zhang NS, Zeng ZY: [Use of en bloc principle in re-operation of thyroid carcinoma]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Apr;44(4):268-71
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Among the eight patients with recurrent laryngeal nerves paralyses which were hurt in the first operation, 4 were found been cut completely, 4 were ligated.
  • The ligated locations were all near the place which the nerve enter the larynx.
  • [MeSH-major] Adenocarcinoma, Papillary / surgery. Thyroid Neoplasms / surgery. Thyroidectomy / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19558829.001).
  • [ISSN] 1673-0860
  • [Journal-full-title] Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
  • [ISO-abbreviation] Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


51. Kim H, Nakaichi M, Itamoto K, Taura Y: Malignant mixed tumor in the salivary gland of a cat. J Vet Sci; 2008 Sep;9(3):331-3
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / veterinary. Cat Diseases / pathology. Cat Diseases / radiography. Chondrosarcoma / veterinary. Salivary Gland Neoplasms / veterinary

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJNR Am J Neuroradiol. 1995 Sep;16(8):1733-5 [7502984.001]
  • [Cites] AJNR Am J Neuroradiol. 1997 Nov-Dec;18(10):1944-8 [9403459.001]
  • [Cites] J Otolaryngol. 2005 Feb;34(1):66-9 [15966481.001]
  • [Cites] Otolaryngol Head Neck Surg. 1999 Nov;121(5):627-32 [10547484.001]
  • [Cites] Australas Radiol. 1999 Nov;43(4):520-2 [10901971.001]
  • [Cites] Pathol Annu. 1993;28 Pt 1:279-328 [8380049.001]
  • [Cites] J Am Anim Hosp Assoc. 2001 Sep-Oct;37(5):478-82 [11563448.001]
  • [Cites] Auris Nasus Larynx. 2003 Dec;30(4):439-42 [14656574.001]
  • [Cites] J Comp Pathol. 1975 Jan;85(1):77-85 [165225.001]
  • [Cites] Arch Otolaryngol. 1984 Mar;110(3):172-6 [6322732.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1986 Jun;61(6):597-602 [3014420.001]
  • [Cites] Arch Pathol Lab Med. 2001 Jun;125(6):812-5 [11371238.001]
  • (PMID = 18716455.001).
  • [ISSN] 1229-845X
  • [Journal-full-title] Journal of veterinary science
  • [ISO-abbreviation] J. Vet. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2811847
  •  go-up   go-down


52. Rieker RJ, Hoegel J, Kern MA, Steger C, Aulmann S, Mechtersheimer G, Schirmacher P, Blaeker H: A mathematical approach predicting the number of events in different tumors. Pathol Oncol Res; 2008 Jun;14(2):199-204

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We used a homogeneous Poisson process to estimate the number of events (N) and the intensity or event rate (lambda) that might be needed for cancer development in various tissues (colon, prostate, oralpharynx, larynx).
  • The expected number of events needed was higher in adenocarcinomas (colorectal carcinoma: N approximately 10 for females and N approximately 11.0 for males; prostatic cancer: N approximately 23) than in squamous cell carcinomas (oropharynx: N approximately 5-6 for females and N approximately 6 for males; larynx: N approximately 7 for females and N approximately 8 males).
  • [MeSH-minor] Adenocarcinoma / epidemiology. Adenocarcinoma / genetics. Adolescent. Adult. Aged. Colorectal Neoplasms / epidemiology. Colorectal Neoplasms / genetics. Computer Simulation. Confidence Intervals. Disease Progression. Female. Humans. Laryngeal Neoplasms / epidemiology. Laryngeal Neoplasms / genetics. Male. Middle Aged. Models, Statistical. Neoplasm Staging. Oropharyngeal Neoplasms / epidemiology. Oropharyngeal Neoplasms / genetics. Poisson Distribution. Prostatic Neoplasms / epidemiology. Prostatic Neoplasms / genetics. Risk Factors. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18431691.001).
  • [ISSN] 1219-4956
  • [Journal-full-title] Pathology oncology research : POR
  • [ISO-abbreviation] Pathol. Oncol. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


53. Ye ZB, Ma T, Li H, Jin XL, Xu HM: Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma. World J Gastroenterol; 2007 Mar 21;13(11):1747-51
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / metabolism. Adenocarcinoma, Mucinous / metabolism. Carcinoma, Signet Ring Cell / metabolism. Interleukin-12 / metabolism. Interleukin-18 / metabolism. Stomach Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] FASEB J. 1999 Dec;13(15):2195-202 [10593867.001]
  • [Cites] Int J Urol. 2004 Aug;11(8):647-52 [15285756.001]
  • [Cites] Int J Biol Markers. 2001 Apr-Jun;16(2):126-9 [11471895.001]
  • [Cites] Clin Otolaryngol Allied Sci. 2001 Aug;26(4):302-6 [11559342.001]
  • [Cites] Cancer. 2001 Oct 15;92(8):2050-5 [11596019.001]
  • [Cites] Auris Nasus Larynx. 2004 Sep;31(3):239-45 [15364358.001]
  • [Cites] In Vivo. 1993 May-Jun;7(3):265-9 [8357968.001]
  • [Cites] J Natl Cancer Inst. 1996 Jan 3;88(1):38-43 [8847724.001]
  • [Cites] J Exp Med. 1997 Mar 3;185(5):817-24 [9120387.001]
  • [Cites] J Clin Invest. 1998 Mar 15;101(6):1441-52 [9502787.001]
  • [Cites] J Immunol. 1999 May 1;162(9):5070-7 [10227975.001]
  • [Cites] AIDS Res Hum Retroviruses. 2005 Jul;21(7):629-43 [16060834.001]
  • [Cites] Cytokine. 2002 Aug 7;19(3):126-37 [12242079.001]
  • [Cites] FASEB J. 2003 Apr;17(6):728-30 [12594171.001]
  • [Cites] Leuk Res. 2004 Jan;28(1):91-5 [14630085.001]
  • [Cites] Curr Opin Immunol. 2004 Apr;16(2):157-62 [15023407.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):734-9 [10639148.001]
  • (PMID = 17461482.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Interleukin-18; 187348-17-0 / Interleukin-12
  • [Other-IDs] NLM/ PMC4146958
  •  go-up   go-down


54. Winter PM, Schmieder AH, Caruthers SD, Keene JL, Zhang H, Wickline SA, Lanza GM: Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits. FASEB J; 2008 Aug;22(8):2758-67
NCI caNanoLab Data Portal. supplemental materials - caNanoLab samples curated from the publication .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, alpha(nu)beta(3)-targeted fumagillin nanoparticles were used to suppress the neovasculature and inhibit Vx-2 adenocarcinoma development using minute drug doses.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Curr Opin Investig Drugs. 2004 Dec;5(12):1243-6 [15648944.001]
  • [Cites] Breast Dis. 2004;20:81-91 [15687710.001]
  • [Cites] Magn Reson Med. 2005 Mar;53(3):621-7 [15723405.001]
  • [Cites] Chem Commun (Camb). 2005 Dec 14;(46):5739-41 [16307130.001]
  • [Cites] Ultrasound Med Biol. 2005 Dec;31(12):1693-700 [16344131.001]
  • [Cites] J Nucl Med. 2006 Jan;47(1):113-21 [16391195.001]
  • [Cites] J Med Chem. 2006 Apr 6;49(7):2268-75 [16570923.001]
  • [Cites] FASEB J. 2006 Apr;20(6):621-30 [16581970.001]
  • [Cites] Eur J Surg Oncol. 2006 May;32(4):363-70 [16520018.001]
  • [Cites] Endothelium. 2006 Mar-Apr;13(2):113-35 [16728329.001]
  • [Cites] Cancer Res. 2003 May 1;63(9):2322-9 [12727857.001]
  • [Cites] Cancer Biother Radiopharm. 2003 Aug;18(4):627-41 [14503959.001]
  • [Cites] Cancer Res. 2003 Sep 15;63(18):5838-43 [14522907.001]
  • [Cites] J Immunol. 2003 Nov 15;171(10):5051-63 [14607902.001]
  • [Cites] Bioconjug Chem. 2004 Jan-Feb;15(1):41-9 [14733582.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1215-27 [15001266.001]
  • [Cites] Bioconjug Chem. 2004 Mar-Apr;15(2):235-41 [15025518.001]
  • [Cites] J Clin Invest. 2004 Jun;113(12):1684-91 [15199403.001]
  • [Cites] Circulation. 2004 Jul 6;110(1):84-90 [15210600.001]
  • [Cites] Cancer Chemother Pharmacol. 2004 Oct;54(4):308-14 [15184994.001]
  • [Cites] Auris Nasus Larynx. 2004 Sep;31(3):239-45 [15364358.001]
  • [Cites] Protein Eng Des Sel. 2004 May;17(5):433-41 [15235124.001]
  • [Cites] Bioconjug Chem. 2004 Sep-Oct;15(5):988-96 [15366951.001]
  • [Cites] J Med Chem. 2004 Sep 23;47(20):4829-37 [15369386.001]
  • [Cites] J Magn Reson Imaging. 2004 Nov;20(5):865-73 [15503324.001]
  • [Cites] Biophys J. 1982 Mar;37(3):657-65 [7074191.001]
  • [Cites] Biochem Soc Trans. 1991 Nov;19(4):835-8 [1794568.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2517-21 [7681600.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7714-8 [7644482.001]
  • [Cites] Cancer. 1996 Apr 15;77(8 Suppl):1736-40 [8608571.001]
  • [Cites] Gynecol Oncol. 1996 Aug;62(2):260-7 [8751559.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9764-9 [8790405.001]
  • [Cites] Eur J Cancer. 1996 Dec;32A(14):2520-7 [9059342.001]
  • [Cites] J Clin Invest. 1997 May 1;99(9):2246-53 [9151798.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6099-103 [9177176.001]
  • [Cites] J Vasc Surg. 1997 Jun;25(6):1061-9 [9201167.001]
  • [Cites] N Engl J Med. 1998 Apr 2;338(14):991-2 [9527612.001]
  • [Cites] Chem Biol. 1999 Nov;6(11):823-33 [10574784.001]
  • [Cites] Biochim Biophys Acta. 2000 Mar 7;1477(1-2):157-67 [10708856.001]
  • [Cites] Int J Cancer. 2000 Mar 20;89(2):153-9 [10754493.001]
  • [Cites] J Cell Biochem. 2000 Apr;77(3):465-73 [10760954.001]
  • [Cites] Int Immunol. 2000 May;12(5):671-6 [10784613.001]
  • [Cites] Ann Oncol. 2006 Sep;17(9):1399-403 [16873427.001]
  • [Cites] Bioconjug Chem. 2006 Sep-Oct;17(5):1294-313 [16984141.001]
  • [Cites] Cancer Res. 2006 Oct 1;66(19):9673-81 [17018625.001]
  • [Cites] Clin Gastroenterol Hepatol. 2006 Nov;4(11):1351-7 [17059898.001]
  • [Cites] Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):770s-776s [17255308.001]
  • [Cites] FASEB J. 2007 Feb;21(2):378-83 [17202248.001]
  • [Cites] Cancer Res. 2007 Feb 15;67(4):1555-62 [17308094.001]
  • [Cites] Int J Cancer. 2007 May 1;120(9):1951-7 [17278104.001]
  • [Cites] Oncologist. 2007 Mar;12(3):356-61 [17405901.001]
  • [Cites] Nano Lett. 2008 Apr;8(4):1131-6 [18302330.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):448-55 [12722742.001]
  • [Cites] Microvasc Res. 2000 May;59(3):368-76 [10792968.001]
  • [Cites] Clin Cancer Res. 2000 May;6(5):1875-81 [10815910.001]
  • [Cites] J Biol Chem. 2000 Jun 16;275(24):18337-43 [10751402.001]
  • [Cites] Clin Cancer Res. 2001 Apr;7(4):977-84 [11309349.001]
  • [Cites] Bioconjug Chem. 2001 Mar-Apr;12(2):213-9 [11312682.001]
  • [Cites] Clin Cancer Res. 2001 May;7(5):1198-203 [11350884.001]
  • [Cites] Cancer Biother Radiopharm. 2001 Apr;16(2):125-32 [11385959.001]
  • [Cites] Circulation. 2001 Sep 11;104(11):1280-5 [11551880.001]
  • [Cites] Nat Med. 2002 Jan;8(1):27-34 [11786903.001]
  • [Cites] Acad Radiol. 2002 May;9 Suppl 1:S261-5 [12019885.001]
  • [Cites] Cancer Res. 2002 Nov 1;62(21):6146-51 [12414640.001]
  • [Cites] Circulation. 2002 Nov 26;106(22):2842-7 [12451012.001]
  • [Cites] J Immunol. 2003 Jan 1;170(1):400-12 [12496425.001]
  • [Cites] Semin Oncol. 2002 Dec;29(6 Suppl 16):15-8 [12516034.001]
  • [Cites] Nat Med. 1998 May;4(5):623-6 [9585240.001]
  • [Cites] Science. 1998 Nov 13;282(5392):1324-7 [9812898.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15183-8 [9860943.001]
  • [Cites] Int J Cancer. 1999 Jan 18;80(2):315-9 [9935216.001]
  • [Cites] Science. 1999 Apr 30;284(5415):808-12 [10221914.001]
  • [Cites] Tumori. 1999 Jan-Feb;85(1):51-3 [10228498.001]
  • [Cites] Clin Cancer Res. 1999 Aug;5(8):1989-95 [10473076.001]
  • (PMID = 18362202.001).
  • [ISSN] 1530-6860
  • [Journal-full-title] FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • [ISO-abbreviation] FASEB J.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CO / N01-CO-27031-16; United States / NINDS NIH HHS / NS / R01 NS059302; United States / NCI NIH HHS / CA / U54 CA119342; United States / NCI NIH HHS / CA / U54 CA136398; United States / NIBIB NIH HHS / EB / EB-01704; United States / NHLBI NIH HHS / HL / HL-73646; United States / NHLBI NIH HHS / HL / HL-78631; United States / NHLBI NIH HHS / HL / R01 HL078631; United States / NCI NIH HHS / CA / CA-119342; United States / NCI NIH HHS / CO / N01-CO-37007; United States / NIBIB NIH HHS / EB / R01 EB001704; United States / NIAID NIH HHS / AI / N01CO37007; United States / NHLBI NIH HHS / HL / R01 HL073646
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Cyclohexanes; 0 / Fatty Acids, Unsaturated; 0 / Integrin alphaVbeta3; 0 / Sesquiterpenes; 7OW73204U1 / fumagillin; EC 3.4.11.- / Aminopeptidases; EC 3.4.11.18 / Methionyl Aminopeptidases
  • [Other-IDs] NLM/ PMC2493462
  •  go-up   go-down


55. Mattsson P, Björck G, Remahl S, Bäckdahl M, Hamberger B, Hydman J, Svensson M: Nimodipine and microsurgery induced recovery of the vocal cord after recurrent laryngeal nerve resection. Laryngoscope; 2005 Oct;115(10):1863-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nimodipine and microsurgery induced recovery of the vocal cord after recurrent laryngeal nerve resection.
  • Transection of the recurrent laryngeal nerve leads to permanent palsy of the vocal cord.
  • We present a case of a 19-year-old male, suffering a thyroid cancer disease, who was subjected to unilateral resection of the recurrent laryngeal nerve during surgery.
  • Evaluation of the patient showed normalization of voice, movement of the vocal cord on the injured side, and electromyography evidence of reinnervation of the larynx muscles at 15 months after surgery.
  • [MeSH-major] Calcium Channel Blockers / therapeutic use. Neurosurgical Procedures / methods. Nimodipine / therapeutic use. Recurrent Laryngeal Nerve Injuries. Sural Nerve / transplantation
  • [MeSH-minor] Adenocarcinoma, Papillary / surgery. Adult. Humans. Male. Microsurgery. Nerve Regeneration / drug effects. Recovery of Function. Thyroid Neoplasms / surgery. Thyroidectomy / adverse effects. Trauma, Nervous System / etiology. Treatment Outcome. Vocal Cord Paralysis / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16222210.001).
  • [ISSN] 0023-852X
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Calcium Channel Blockers; 57WA9QZ5WH / Nimodipine
  •  go-up   go-down


56. Cercato MC, Colella E, Ferraresi V, Diodoro MG, Tonachella R: Report of two cases of quintuple primary malignancies and review of the literature. Anticancer Res; 2008 Sep-Oct;28(5B):2953-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Two patients surviving five primary malignant neoplasms for 12 and 18 years are reported: a 55-year-old woman with a squamous cell carcinoma of the larynx, two carcinomas of the breast, a carcinoma of the kidney and an adenocarcinoma of the colon, and a 75-year-old woman with a sarcoma of the myometrium, a carcinoma of the thyroid, an adenocarcinoma of the rectum, a leiomyosarcoma of the colon and a bronchial carcinoid.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19031939.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


57. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A: Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg; 2006 May;30(5):780-6
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the most recent version of the UICC TNM classification system, extrathyroid extension has been classified into two grades, minimal extension (extension to sternothyroid muscle or perithyroid soft tissues) and massive extension (extension to subcutaneous soft tissue, larynx, trachea, esophagus, or recurrent laryngeal nerve).
  • CONCLUSIONS: These findings suggest that (1) upgrading of T category for tumors with massive extension is appropriate, whereas that for tumors with only minimal extension is not, and (2) careful surgical treatment and postoperative follow-up are required for tumors with massive extension to posterior organs other than the recurrent laryngeal nerve.
  • [MeSH-major] Adenocarcinoma, Papillary / pathology. Neoplasm Recurrence, Local / mortality. Thyroid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16411013.001).
  • [ISSN] 0364-2313
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


58. Hatano A, Nakajima M, Kato T, Moriyama H: Craniofacial resection for malignant nasal and paranasal sinus tumors assisted with the endoscope. Auris Nasus Larynx; 2009 Feb;36(1):42-5
MedlinePlus Health Information. consumer health - Nasal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / surgery. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / surgery. Humans. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Recurrence, Local / pathology. Neoplasm Recurrence, Local / surgery. Osteotomy

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18486380.001).
  • [ISSN] 1879-1476
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


59. Doobaree IU, Landis SH, Linklater KM, El-Hariry I, Moller H, Tyczynski J: Head and neck cancer in South East England between 1995-1999 and 2000-2004: An estimation of incidence and distribution by site, stage and histological type. Oral Oncol; 2009 Sep;45(9):809-14
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The three commonest HNC sites were intra-oral cavity, larynx and tonsil.
  • Males were two to six times as likely as females to be diagnosed with HNC and there was a trend toward younger age at diagnosis over time.
  • Conversely, laryngeal cancer incidence decreased over time.
  • [MeSH-minor] Adenocarcinoma / epidemiology. Adenocarcinoma / pathology. Adolescent. Adult. Age Distribution. Aged. Carcinoma, Squamous Cell / epidemiology. Carcinoma, Squamous Cell / pathology. Child. Child, Preschool. England / epidemiology. Female. Humans. Incidence. Infant. Infant, Newborn. Male. Middle Aged. Registries. Sex Distribution. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19251472.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


60. Cao Z, Gu Z, Yang J, Jin M: Respiratory epithelial adenomatoid hamartoma of bilateral olfactory clefts associated with nasal polyposis: three cases report and literature review. Auris Nasus Larynx; 2010 Jun;37(3):352-6
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although REAH arising from the rhinosinusal region is very rare, rhinolaryngologists should know this entity thoroughly in order to differentiate it from inverted papilloma and adenocarcinoma, since misinterpretation of this lesion may result in aggressive surgery for a benign lesion which could greatly affect patient's quality of life after operation.
  • [MeSH-minor] Diagnosis, Differential. Endoscopy / methods. Female. Humans. Male. Middle Aged. Quality of Life / psychology

  • MedlinePlus Health Information. consumer health - Brain Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 19942387.001).
  • [ISSN] 1879-1476
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 12
  •  go-up   go-down


61. Stiles BM, Mirza F, Port JL, Lee PC, Paul S, Christos P, Altorki NK: Predictors of cervical and recurrent laryngeal lymph node metastases from esophageal cancer. Ann Thorac Surg; 2010 Dec;90(6):1805-11; discussion 1811
MedlinePlus Health Information. consumer health - Esophageal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Predictors of cervical and recurrent laryngeal lymph node metastases from esophageal cancer.
  • BACKGROUND: Although patients with esophageal cancer (EC) often develop lymph node metastases in the cervical and recurrent laryngeal (CRL) distribution, lymphadenectomy in this field is rarely performed.
  • Low rates of positive CRL nodes are present with early clinical stage, with pT0-2 tumors, and with pN0 classification, particularly in patients with adenocarcinoma and gastroesophageal junction tumors.
  • Dissection of the CRL field should be considered with advanced disease for adenocarcinoma and in all patients with squamous cell cancer.
  • [MeSH-major] Esophageal Neoplasms / secondary. Lymph Node Excision / methods. Lymph Nodes / pathology. Lymphatic Metastasis / diagnosis. Neoplasm Recurrence, Local / prevention & control
  • [MeSH-minor] Combined Modality Therapy. Female. Follow-Up Studies. Humans. Incidence. Larynx. Male. Neck. Neoplasm Staging. New York / epidemiology. Odds Ratio. Prognosis. Retrospective Studies. Risk Factors

  • Genetic Alliance. consumer health - Esophageal Cancer.
  • Genetic Alliance. consumer health - Laryngeal cancer.
  • Genetic Alliance. consumer health - Cervical cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
  • (PMID = 21095315.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Grant] United States / NCRR NIH HHS / RR / UL1-RR024996
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] Netherlands
  •  go-up   go-down


62. Picciotti PM, Calò L, Mulè A, Maggiore C, Scarano E: Rhino sinusal bilateral hamartoma: a case report. Auris Nasus Larynx; 2008 Dec;35(4):569-71
MedlinePlus Health Information. consumer health - Nose Injuries and Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although hamartoma arising from the rhino sinusal region is very rare, head and neck surgeons must know this entity in order to differentiate it from inverted papilloma and adenocarcinoma.
  • [MeSH-major] Ethmoid Sinus / surgery. Hamartoma / diagnosis. Maxillary Sinus / surgery. Nose Diseases / diagnosis. Paranasal Sinus Diseases / diagnosis
  • [MeSH-minor] Diagnosis, Computer-Assisted. Endoscopy. Humans. Male. Middle Aged. Nasal Mucosa / pathology. Nasal Obstruction / diagnosis. Nasal Obstruction / pathology. Nasal Obstruction / surgery. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18207343.001).
  • [ISSN] 1879-1476
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


63. Illanes D, Broman J, Meyer B, Kredentser D, McElrath T, Timmins P 3rd: Verrucous carcinoma of the endometrium: case history, pathologic findings, brief review of literature and discussion. Gynecol Oncol; 2006 Aug;102(2):375-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A defined disease of the oral cavity, larynx, esophagus, skin, vulva, vagina and cervix.
  • But a verrucous carcinoma arising from the endometrium without evidence of cervical malignancy or endometrial adenocarcinoma is extremely rare.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16529798.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


64. Yamashita Y, Ishiguro Y, Sano D, Kimura M, Fujita K, Yoshida T, Horiuchi C, Taguchi T, Matsuda H, Mikami Y, Tsukuda M: Antitumor effects of Nafamostat mesilate on head and neck squamous cell carcinoma. Auris Nasus Larynx; 2007 Dec;34(4):487-91
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: Nafamostat mesilate (FUT-175), a synthetic serine protease inhibitor, has antitumor activities toward adenocarcinoma, e.g., colon cancer.
  • [MeSH-major] Antineoplastic Agents / pharmacology. Carcinoma, Squamous Cell / pathology. Cell Division / drug effects. Cell Survival / drug effects. Guanidines / pharmacology. Hypopharyngeal Neoplasms / pathology. Laryngeal Neoplasms / pathology. Transforming Growth Factor beta1 / genetics. Tumor Cells, Cultured / drug effects. Tumor Stem Cell Assay. Vascular Endothelial Growth Factor A / genetics

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17337140.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Guanidines; 0 / RNA, Messenger; 0 / Transforming Growth Factor beta1; 0 / Vascular Endothelial Growth Factor A; EC 3.4.24.24 / MMP2 protein, human; EC 3.4.24.24 / Matrix Metalloproteinase 2; EC 3.4.24.35 / Matrix Metalloproteinase 9; Y25LQ0H97D / nafamostat
  •  go-up   go-down


65. Nishida AT, Hirano S, Asato R, Tanaka S, Kitani Y, Honda N, Fujiki N, Miyata K, Fukushima H, Ito J: Multifocal hyperfunctioning thyroid carcinoma without metastases. Auris Nasus Larynx; 2008 Sep;35(3):432-6
Hazardous Substances Data Bank. TECHNETIUM, ELEMENTAL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma, Papillary / diagnosis. Hyperthyroidism / diagnosis. Neoplasms, Multiple Primary / diagnosis. Thyroid Neoplasms / diagnosis. Thyroid Nodule / diagnosis

  • MedlinePlus Health Information. consumer health - Hyperthyroidism.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17826928.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 7440-26-8 / Technetium
  •  go-up   go-down


66. Vasudev P, Boutross-Tadross O, Radhi J: Basaloid squamous cell carcinoma: two case reports. Cases J; 2009;2:9351
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BSCC of the head and neck should be distinguished from adenoid cystic carcinoma, small cell neuroendocrine carcinoma, basal cell adenocarcinoma, adenosquamous carcinoma, squamous cell carcinoma, spindle cell squamous carcinoma, mucoepidermoid carcinoma, and adenoid cystic carcinoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Cancer. 2008 Jan;44(2):244-50 [18096379.001]
  • [Cites] Auris Nasus Larynx. 2007 Mar;34(1):119-23 [17141998.001]
  • [Cites] Histopathology. 2000 Sep;37(3):218-23 [10971697.001]
  • [Cites] Hum Pathol. 1986 Nov;17(11):1158-66 [3770734.001]
  • [Cites] Ophthalmology. 1993 Nov;100(11):1720-2 [8233401.001]
  • (PMID = 20062602.001).
  • [ISSN] 1757-1626
  • [Journal-full-title] Cases journal
  • [ISO-abbreviation] Cases J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2804002
  •  go-up   go-down


67. Biel MA: Photodynamic therapy of head and neck cancers. Methods Mol Biol; 2010;635:281-93
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The predominant histology is squamous cell carcinoma, but other histologies treated include mucosal melanoma, Kaposi's sarcoma, adenocarcinoma, metastatic breast carcinoma, and adenoid cystic carcinoma.
  • Patients with early stage cancers or early recurrences in the oral cavity and larynx (Cis, T1, T2) tend to have an excellent response to PDT.
  • Of 518 patients treated with Cis, T1, or T2 cancers of the oral cavity, larynx, pharynx, and nasopharynx, 462 (89.1%) obtained a complete clinical response after one PDT treatment.
  • Laryngeal cancers, comprising 171 patients in this group, obtained a durable complete response rate of 89% with up to a 16-year follow-up.

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20552353.001).
  • [ISSN] 1940-6029
  • [Journal-full-title] Methods in molecular biology (Clifton, N.J.)
  • [ISO-abbreviation] Methods Mol. Biol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


68. Yilmaz I, Bolat F, Demirhan B, Aydin V, Ozluoglu LN: Endolymphatic sac papillary tumor: a case report and review. Auris Nasus Larynx; 2008 Jun;35(2):276-81

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Endolymphatic sac papillary tumor (endolymphatic sac adenoma, temporal-mastoid bone adenoma or adenocarcinoma, low-grade adenocarcinoma of potential endolymphatic sac origin, aggressive papillary tumor of the temporal bone, Heffner's tumor) is a rare lesion that involves the temporal bone.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17855033.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 20
  •  go-up   go-down


69. Cohen M, Cassarino DS, Shih HB, Abemayor E, St John M: Apocrine hidradenocarcinoma of the scalp: a classification conundrum. Head Neck Pathol; 2009 Mar;3(1):42-6
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / classification. Apocrine Glands / pathology. Head and Neck Neoplasms / classification. Scalp / pathology. Sweat Gland Neoplasms / classification

  • Genetic Alliance. consumer health - Hidradenocarcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 2003 May 1;97(9):2285-9 [12712485.001]
  • [Cites] Auris Nasus Larynx. 2003 Aug;30(3):307-10 [12927299.001]
  • [Cites] Dermatol Surg. 2004 Sep;30(9):1265-8 [15355375.001]
  • [Cites] Dermatol Surg. 2004 Dec;30(12 Pt 2):1574-9 [15606845.001]
  • [Cites] Am J Surg Pathol. 2008 May;32(5):682-90 [18347508.001]
  • [Cites] J Cutan Pathol. 2006 Nov;33(11):726-30 [17083691.001]
  • [Cites] Head Neck. 2007 Feb;29(2):193-7 [17103407.001]
  • [Cites] J Clin Pathol. 2007 Feb;60(2):145-59 [16882695.001]
  • [Cites] J Clin Pathol. 2007 Feb;60(2):129-44 [16882696.001]
  • [Cites] Mod Pathol. 2006 Feb;19 Suppl 2:S93-S126 [16446719.001]
  • (PMID = 20596988.001).
  • [ISSN] 1936-0568
  • [Journal-full-title] Head and neck pathology
  • [ISO-abbreviation] Head Neck Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Other-IDs] NLM/ PMC2807530
  • [Keywords] NOTNLM ; Apocrine / Eccrine / Head / Hidradenocarcinoma / Neck / Scalp / Sweat gland
  •  go-up   go-down


70. Aydin E, Turkoglu S, Ozen O, Akkuzu B: Mucinous cystadenocarcinoma of a minor salivary gland in the upper lip: case report. Auris Nasus Larynx; 2005 Sep;32(3):301-4
MedlinePlus Health Information. consumer health - Salivary Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The differential diagnosis includes mucoepidermoid carcinoma, acinic cell carcinoma, salivary duct carcinoma, nasal adenocarcinoma, and metastatic carcinoma.
  • The pathological diagnosis was low-grade mucinous cystadenocarcinoma of a minor salivary gland.
  • [MeSH-major] Cystadenocarcinoma, Mucinous / diagnosis. Cystadenocarcinoma, Mucinous / pathology. Lip / surgery. Salivary Gland Neoplasms / diagnosis. Salivary Gland Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15923100.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


71. Crain N, Nelson BL, Barnes EL, Thompson LD: Ceruminous gland carcinomas: a clinicopathologic and immunophenotypic study of 17 cases. Head Neck Pathol; 2009 Mar;3(1):1-17

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumors were divided into three types of adenocarcinoma based on pattern of growth and cell type (ceruminous, NOS [n = 12], adenoid cystic [n = 4], mucoepidermoid [n = 1]).
  • Metastatic adenocarcinoma or direct extension from salivary gland neoplasms are the principle differential considerations.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Thorac Cardiovasc Surg. 1973 Jun;65(6):909-13 [4350087.001]
  • [Cites] J Laryngol Otol. 1973 Dec;87(12):1201-10 [4357381.001]
  • [Cites] J Laryngol Otol. 1974 Apr;88(4):363-8 [4824672.001]
  • [Cites] Can J Otolaryngol. 1974;3(2):194-201 [4831936.001]
  • [Cites] Arch Otolaryngol. 1974 Nov;100(5):395-7 [4429488.001]
  • [Cites] Cancer. 1975 Sep;36(3):1072-6 [171051.001]
  • [Cites] J Laryngol Otol. 1975 Jul;89(7):707-20 [171328.001]
  • [Cites] Arch Otolaryngol. 1975 Nov;101(11):702-5 [1200915.001]
  • [Cites] Laryngoscope. 1977 Oct;87(10 Pt 1):1601-12 [198620.001]
  • [Cites] J Can Assoc Radiol. 1977 Dec;28(4):287-90 [303644.001]
  • [Cites] Cancer. 1978 Feb;41(2):545-53 [630537.001]
  • [Cites] Arch Otolaryngol. 1980 Jan;106(1):13-9 [6243462.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1990 Sep;99(9 Pt 1):714-21 [2396807.001]
  • [Cites] Neurol Med Chir (Tokyo). 1990 Dec;30(13):1034-7 [1714051.001]
  • [Cites] Otolaryngol Head Neck Surg. 1992 Feb;106(2):214-5 [1310808.001]
  • [Cites] Acta Morphol Hung. 1991;39(2):157-65 [1789146.001]
  • [Cites] J Laryngol Otol. 1992 Aug;106(8):727-32 [1328435.001]
  • [Cites] Pathology. 1992 Oct;24(4):315-9 [1337771.001]
  • [Cites] Rev Laryngol Otol Rhinol (Bord). 1993;114(1):49-52 [8191051.001]
  • [Cites] J Laryngol Otol. 1994 Aug;108(8):706-9 [7930929.001]
  • [Cites] Cancer. 1982 Dec 15;50(12):2873-83 [6291744.001]
  • [Cites] J Laryngol Otol. 1995 Mar;109(3):180-8 [7745330.001]
  • [Cites] Am J Dermatopathol. 1995 Apr;17(2):169-73 [8600783.001]
  • [Cites] J Laryngol Otol. 1996 Mar;110(3):249-51 [8730361.001]
  • [Cites] J Am Anim Hosp Assoc. 1996 Sep-Oct;32(5):448-52 [8875362.001]
  • [Cites] Indian J Cancer. 1997 Sep;34(3):139-42 [9491676.001]
  • [Cites] Br J Plast Surg. 1998 Jun;51(4):317-20 [9771352.001]
  • [Cites] J Laryngol Otol. 1957 Dec;71(12):824-31 [13491925.001]
  • [Cites] J Laryngol Otol. 1957 Dec;71(12):832-7 [13491926.001]
  • [Cites] Cancer. 1964 Jan;17:67-75 [14102073.001]
  • [Cites] J Otolaryngol. 1980 Dec;9(6):482-6 [6162967.001]
  • [Cites] J Laryngol Otol. 1981 Aug;95(8):843-8 [6267150.001]
  • [Cites] J Neurosurg. 1981 Dec;55(6):952-6 [7299469.001]
  • [Cites] Am J Clin Pathol. 1982 Feb;77(2):153-61 [7039299.001]
  • [Cites] Laryngoscope. 1983 Mar;93(3):326-40 [6300574.001]
  • [Cites] Hiroshima J Med Sci. 1984 Mar;33(1):17-22 [6090347.001]
  • [Cites] J Am Acad Dermatol. 1984 Nov;11(5 Pt 1):841-7 [6096419.001]
  • [Cites] Laryngoscope. 1987 Feb;97(2):158-64 [3807618.001]
  • [Cites] Am J Otol. 1987 Nov;8(6):485-8 [3434612.001]
  • [Cites] Cancer. 1989 Dec 1;64(11):2292-302 [2804921.001]
  • [Cites] J R Soc Med. 1990 Jan;83(1):34-7 [2406442.001]
  • [Cites] J Laryngol Otol. 1999 Jun;113(6):578-80 [10605594.001]
  • [Cites] J Otolaryngol. 2001 Dec;30(6):373-7 [11771014.001]
  • [Cites] Arch Pathol Lab Med. 2002 Jan;126(1):87-9 [11800656.001]
  • [Cites] J Oral Maxillofac Surg. 2002 Apr;60(4):465-9 [11928113.001]
  • [Cites] Mod Pathol. 2002 May;15(5):543-55 [12011260.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2002 Jul;128(7):834-7 [12117346.001]
  • [Cites] ORL J Otorhinolaryngol Relat Spec. 2002 Sep-Oct;64(5):358-63 [12417781.001]
  • [Cites] J Laryngol Otol. 2003 Mar;117(3):202-4 [12648377.001]
  • [Cites] Am J Otolaryngol. 2003 Jul-Aug;24(4):274-7 [12884224.001]
  • [Cites] Acta Otorhinolaryngol Ital. 2004 Dec;24(6):354-6 [15952686.001]
  • [Cites] Ear Nose Throat J. 2005 Sep;84(9):560-1 [16261754.001]
  • [Cites] Otol Neurotol. 2006 Jan;27(1):97-101 [16371854.001]
  • [Cites] Indian J Pathol Microbiol. 2006 Oct;49(4):587-9 [17183866.001]
  • [Cites] Acta Otolaryngol. 2007 Mar;127(3):280-4 [17364365.001]
  • [Cites] Otolaryngol Head Neck Surg. 2007 Dec;137(6):893-8 [18036417.001]
  • [Cites] J Neurosurg. 2008 Jan;108(1):97-104 [18173317.001]
  • [Cites] B-ENT. 2007;3(4):195-9 [18265725.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2008 Jun;134(6):663-6 [18559737.001]
  • [Cites] Laryngoscope. 2008 Sep;118(9):1591-6 [18677277.001]
  • [Cites] Auris Nasus Larynx. 2003 Aug;30(3):287-90 [12927294.001]
  • [Cites] Acta Cytol. 2003 Sep-Oct;47(5):792-4 [14526681.001]
  • [Cites] ORL J Otorhinolaryngol Relat Spec. 2003 Sep-Oct;65(5):300-2 [14730188.001]
  • [Cites] J Laryngol Otol. 2003 Dec;117(12):951-4 [14738604.001]
  • [Cites] Am J Surg Pathol. 2004 Mar;28(3):308-18 [15104293.001]
  • [Cites] Arch Otolaryngol. 1967 Jul;86(1):66-9 [6026961.001]
  • [Cites] Arch Dermatol. 1968 Oct;98(4):344-8 [4300211.001]
  • [Cites] Arch Otolaryngol. 1970 Jul;92(1):40-2 [4192890.001]
  • [Cites] J Laryngol Otol. 1970 Jul;84(7):743-5 [5432829.001]
  • [Cites] Pract Otorhinolaryngol (Basel). 1970;32(4):211-8 [5477506.001]
  • [Cites] Cancer. 1971 Sep;28(3):775-80 [4328926.001]
  • [Cites] Tex Med. 1970 Oct;66(10):56-9 [4335213.001]
  • [Cites] Cancer. 1972 May;29(5):1169-78 [5021609.001]
  • (PMID = 20596983.001).
  • [ISSN] 1936-0568
  • [Journal-full-title] Head and neck pathology
  • [ISO-abbreviation] Head Neck Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Other-IDs] NLM/ PMC2807538
  • [Keywords] NOTNLM ; Adenoid cystic / Carcinoma / Ceruminal / Ceruminous / Ear / Gland / Immunohistochemistry / Mucoepidermoid / Prognosis
  •  go-up   go-down


72. Basseri B, Conklin JL, Mertens RB, Lo SK, Bellack GS, Shaye OA: Heterotopic gastric mucosa (inlet patch) in a patient with laryngopharyngeal reflux (LPR) and laryngeal carcinoma: a case report and review of literature. Dis Esophagus; 2009;22(4):E1-5
MedlinePlus Health Information. consumer health - GERD.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Heterotopic gastric mucosa (inlet patch) in a patient with laryngopharyngeal reflux (LPR) and laryngeal carcinoma: a case report and review of literature.
  • Esophageal and supraesophageal symptoms are commonly associated with inlet patch, while esophageal adenocarcinoma rarely complicates it.
  • Laryngeal adenocarcinoma associated with inlet patch is not described in the literature.
  • Herein, we present the first reported case of inlet patch associated with laryngeal carcinoma.
  • A 33-year-old female with long-standing asthma and presumed gastroesophageal reflux developed laryngeal cancer at age 22 years that was treated with concomitant radiation and induction chemotherapy.
  • This case reveals a number of clinical findings associated with inlet patch--chest pain, dysphagia, cough, and hoarseness--as well as a clinical finding that has not been previously associated with inlet patch: laryngeal cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19473208.001).
  • [ISSN] 1442-2050
  • [Journal-full-title] Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
  • [ISO-abbreviation] Dis. Esophagus
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 30
  •  go-up   go-down


73. Hammer HF: Reflux-associated laryngitis and laryngopharyngeal reflux: a gastroenterologist's point of view. Dig Dis; 2009;27(1):14-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The laryngeal mucosa is considerably more sensitive to acid and pepsin than the mucosa of the esophagogastric junction.
  • Therefore definitions of acid and nonacid reflux used for gastroesophageal reflux disease may not be helpful for explaining pathophysiologic mechanisms in the larynx or pharynx.
  • Since symptoms of laryngopharyngeal reflux may predict esophageal adenocarcinoma, every patient with laryngopharyngeal reflux should have an upper gastrointestinal endoscopy, even if no classical symptoms of gastroesophageal reflux disease are present.
  • [MeSH-major] Gastroesophageal Reflux / complications. Hypopharynx / pathology. Laryngeal Diseases / etiology. Laryngitis / etiology. Laryngoscopy
  • [MeSH-minor] Gastrointestinal Agents / therapeutic use. Hoarseness / etiology. Hoarseness / pathology. Humans. Laryngeal Mucosa / pathology. Proton Pump Inhibitors. Treatment Failure

  • MedlinePlus Health Information. consumer health - GERD.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19439955.001).
  • [ISSN] 1421-9875
  • [Journal-full-title] Digestive diseases (Basel, Switzerland)
  • [ISO-abbreviation] Dig Dis
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Gastrointestinal Agents; 0 / Proton Pump Inhibitors
  • [Number-of-references] 20
  •  go-up   go-down


74. Magakian IuA, Karalova EM, Karalian ZA, Abroian LO, Akopian LA, Gasparian MG, Dzhagatspanian NG, Semerdzhian ZB, Ter-Pogosian ZP: [Multiparametric study and cluster-analysis of the transformed cultures of human cells]. Tsitologiia; 2009;51(1):20-5
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The cells of nepatocarcinoma (HEp-G2), adenocarcinoma of large intestine (Caco-2), embryonal kidney (HEK-293), neuroblastoma (SH-SY5Y), rabdomyosarcoma (RD), and larynx cancer (Hep-2) were studied by the methods of scanning cytophotometry, cytochemistry and cytomorphometry during 96 h of cultivation.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19281045.001).
  • [ISSN] 0041-3771
  • [Journal-full-title] Tsitologiia
  • [ISO-abbreviation] Tsitologiia
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 9007-49-2 / DNA
  •  go-up   go-down


75. Yilmaz A, Ertugrul M, Yagci Tuncer L, Sulu E, Damadoglu E: Multiple primary malignancies involving lung: an analysis of 40 cases. Ups J Med Sci; 2008;113(2):193-200
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumour pathology of the lung was squamous cell carcinoma in 15 cases, adenocarcinoma in 10 cases, small cell carcinoma in 3 cases and non-small cell carcinoma in 12 cases.
  • The first detected tumour was located in larynx in 11 cases, in genitourinary system in 9 cases, in intestine in 5 cases, in lung in 3 cases and in other organs in 12 cases.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18509813.001).
  • [ISSN] 2000-1967
  • [Journal-full-title] Upsala journal of medical sciences
  • [ISO-abbreviation] Ups. J. Med. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Sweden
  •  go-up   go-down


76. Vargas PA, Speight PM, Bingle CD, Barrett AW, Bingle L: Expression of PLUNC family members in benign and malignant salivary gland tumours. Oral Dis; 2008 Oct;14(7):613-9
antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MATERIALS AND METHODS: A tissue microarray was assembled from 64 salivary gland tumours including adenoid cystic carcinoma, carcinoma ex-pleomorphic adenoma, mucoepidermoid carcinoma, polymorphous low-grade adenocarcinoma, pleomorphic adenoma, acinic cell carcinoma, myoepithelial carcinoma and papillary cystadenocarcinoma.

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Dent Res. 2005 Feb;84(2):149-53 [15668332.001]
  • [Cites] J Pathol. 2005 Mar;205(4):491-7 [15685591.001]
  • [Cites] J Proteome Res. 2006 Jun;5(6):1469-78 [16739998.001]
  • [Cites] J Proteome Res. 2006 Jun;5(6):1493-503 [16740002.001]
  • [Cites] J Oral Pathol Med. 2006 Aug;35(7):392-401 [16827841.001]
  • [Cites] J Laryngol Otol. 2006 Dec;120(12):1077-80 [16995970.001]
  • [Cites] J Oral Pathol Med. 2007 Jul;36(6):371-6 [17559500.001]
  • [Cites] J Biol Chem. 1992 Feb 5;267(4):2679-87 [1370829.001]
  • [Cites] Proteomics. 2004 Apr;4(4):1109-15 [15048992.001]
  • [Cites] Genetics. 1980 May;95(1):129-41 [6159249.001]
  • [Cites] Protein Sci. 2004 Feb;13(2):422-30 [14739326.001]
  • [Cites] Br J Cancer. 2003 Nov 17;89(10):1940-9 [14612907.001]
  • [Cites] J Mol Diagn. 2003 Nov;5(4):237-42 [14573783.001]
  • [Cites] Biochem Soc Trans. 2003 Aug;31(Pt 4):777-80 [12887304.001]
  • [Cites] Genes Chromosomes Cancer. 2003 Sep;38(1):80-90 [12874788.001]
  • [Cites] Rev Hosp Clin Fac Med Sao Paulo. 2002 Nov-Dec;57(6):271-6 [12612759.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1099-104 [12538848.001]
  • [Cites] Clin Chem. 2003 Feb;49(2):312-5 [12560358.001]
  • [Cites] Oral Dis. 2002 Sep;8(5):229-40 [12363107.001]
  • [Cites] Hum Mol Genet. 2002 Apr 15;11(8):937-43 [11971875.001]
  • [Cites] Auris Nasus Larynx. 2002 Jan;29(1):87-90 [11772498.001]
  • [Cites] Int J Cancer. 2001 Feb 15;91(4):433-7 [11251963.001]
  • [Cites] Biochim Biophys Acta. 2000 Oct 2;1493(3):363-7 [11018263.001]
  • [Cites] Am J Surg Pathol. 1996 Dec;20(12):1440-7 [8944036.001]
  • [Cites] Diagn Cytopathol. 1998 Oct;19(4):244-9 [9784985.001]
  • [Cites] J Biol Chem. 1999 May 7;274(19):13698-703 [10224143.001]
  • [Cites] J Oral Pathol Med. 1993 Aug;22(7):327-30 [8229870.001]
  • (PMID = 18221458.001).
  • [ISSN] 1601-0825
  • [Journal-full-title] Oral diseases
  • [ISO-abbreviation] Oral Dis
  • [Language] ENG
  • [Grant] United Kingdom / Wellcome Trust / / 076491; United Kingdom / Wellcome Trust / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / BPIFA1 protein, human; 0 / Biomarkers, Tumor; 0 / Glycoproteins; 0 / Phosphoproteins
  • [Other-IDs] NLM/ PMC2853704; NLM/ UKMS29166
  •  go-up   go-down


77. Uliana M, Della Seta R, Penucci MC, Marini P: [Three different kinds of tumor in the same patient. Correlation with the lifestyle]. Recenti Prog Med; 2007 Sep;98(9):443-4
MedlinePlus Health Information. consumer health - Smoking.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A patient was a heavy smoker and drinker, so during his life has developed three cancers: larynx, liver and lung.
  • [MeSH-major] Adenocarcinoma / etiology. Alcohol Drinking / adverse effects. Carcinoma, Hepatocellular / etiology. Carcinoma, Small Cell / etiology. Laryngeal Neoplasms / etiology. Life Style. Liver Neoplasms / etiology. Lung Neoplasms / etiology. Neoplasms, Second Primary / etiology. Smoking / adverse effects

  • MedlinePlus Health Information. consumer health - Alcohol.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17902569.001).
  • [ISSN] 0034-1193
  • [Journal-full-title] Recenti progressi in medicina
  • [ISO-abbreviation] Recenti Prog Med
  • [Language] ita
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


78. Kothe C, Fleischer S, Grundmann T, Hess M: [Bright white vocal folds and capillary ectasias. Late sequelae after radiotherapy]. HNO; 2006 Apr;54(4):312-4
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report on visible laryngeal changes after radiotherapy.
  • The larynx was examined by video-laryngoscopy and stroboscopy.
  • [MeSH-major] Adenocarcinoma, Follicular / radiotherapy. Esophageal Neoplasms / radiotherapy. Radiation Injuries / diagnosis. Thyroid Neoplasms / radiotherapy. Vocal Cords / radiation effects

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16528509.001).
  • [ISSN] 0017-6192
  • [Journal-full-title] HNO
  • [ISO-abbreviation] HNO
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


79. Sis B, Sarioglu S, Sokmen S, Sakar M, Kupelioglu A, Fuzun M: Desmoplasia measured by computer assisted image analysis: an independent prognostic marker in colorectal carcinoma. J Clin Pathol; 2005 Jan;58(1):32-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / pathology. Colorectal Neoplasms / pathology. Image Processing, Computer-Assisted / methods

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 2000 Apr 1;88(7):1739-57 [10738234.001]
  • [Cites] Cancer Res. 2000 May 1;60(9):2497-503 [10811131.001]
  • [Cites] Arch Pathol Lab Med. 2000 Jul;124(7):979-94 [10888773.001]
  • [Cites] Nature. 2001 May 17;411(6835):375-9 [11357145.001]
  • [Cites] Int J Cancer. 1993 Jul 30;54(6):1010-6 [8335394.001]
  • [Cites] Int J Cancer. 1994 Feb 15;56(4):512-21 [8112888.001]
  • [Cites] Physiol Rev. 1996 Jan;76(1):69-125 [8592733.001]
  • [Cites] Pathol Res Pract. 1996 Jul;192(7):712-7 [8880872.001]
  • [Cites] Am J Pathol. 1997 Feb;150(2):497-507 [9033266.001]
  • [Cites] Cancer. 1997 Mar 1;79(5):915-9 [9041153.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1997 Apr;106(4):271-8 [9109715.001]
  • [Cites] Pathol Int. 1998 Jan;48(1):1-9 [9589457.001]
  • [Cites] Lab Invest. 1998 May;78(5):511-22 [9605176.001]
  • [Cites] Int J Cancer. 1999 May 17;81(4):629-36 [10225455.001]
  • [Cites] Auris Nasus Larynx. 2004 Dec;31(4):417-24 [15571917.001]
  • [Cites] J Clin Pathol. 2001 Jun;54(6):461-5 [11376020.001]
  • [Cites] J Hepatol. 2001 May;34(5):740-7 [11434621.001]
  • [Cites] Histopathology. 2001 Oct;39(4):416-25 [11683944.001]
  • [Cites] Nat Rev Cancer. 2002 Jan;2(1):38-47 [11902584.001]
  • [Cites] Anticancer Res. 2001 Nov-Dec;21(6B):4341-8 [11908689.001]
  • [Cites] Clin Exp Metastasis. 2002;19(1):55-60 [11918083.001]
  • [Cites] Cancer Res. 2002 Jun 1;62(11):3298-307 [12036948.001]
  • [Cites] Int J Biochem Cell Biol. 2002 Nov;34(11):1401-14 [12200035.001]
  • [Cites] Cancer. 2002 Dec 15;95(12):2546-54 [12467069.001]
  • [Cites] J Am Soc Nephrol. 2003 Jun;14(6):1662-8 [12761269.001]
  • [Cites] J Pathol. 2003 Jul;200(4):429-47 [12845611.001]
  • [Cites] Br J Cancer. 2003 Sep 1;89(5):870-6 [12942120.001]
  • [Cites] Breast Cancer Res Treat. 2003 Sep;81(2):137-47 [14572156.001]
  • [Cites] Tumori. 2003 Jul-Aug;89(4):343-8 [14606634.001]
  • [Cites] Tohoku J Exp Med. 2003 Oct;201(2):67-73 [14626507.001]
  • [Cites] Cancer Res. 1987 Mar 15;47(6):1663-7 [3815362.001]
  • [Cites] J Clin Pathol. 1989 Feb;42(2):162-6 [2921357.001]
  • [Cites] Int J Cancer. 1993 Jan 2;53(1):62-9 [7677932.001]
  • [Cites] Int J Dev Biol. 1993 Mar;37(1):203-11 [8507562.001]
  • (PMID = 15623479.001).
  • [ISSN] 0021-9746
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1770537
  •  go-up   go-down


80. Haigentz M Jr, Silver CE, Hartl DM, Takes RP, Rodrigo JP, Robbins KT, Rinaldo A, Ferlito A: Chemotherapy regimens and treatment protocols for laryngeal cancer. Expert Opin Pharmacother; 2010 Jun;11(8):1305-16
Genetic Alliance. consumer health - Laryngeal cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chemotherapy regimens and treatment protocols for laryngeal cancer.
  • IMPORTANCE OF THE FIELD: Laryngeal cancer has been the model of curative-intent organ-preserving therapies in clinical oncology.
  • Although the optimal care of patients with laryngeal cancer is truly multidisciplinary, with progressive advances in surgical, radiation, and medical oncology, the development of effective systemic therapies has been a major component of the therapeutic arsenal against laryngeal cancer.
  • AREAS COVERED IN THIS REVIEW: This review will discuss the rapidly evolving roles of chemotherapy in the management of locally advanced and metastatic laryngeal cancer.
  • WHAT THE READER WILL GAIN: The reader will gain a historical perspective on this evolution in treatment and will appreciate current treatment challenges and promising future directions in optimizing therapeutic efficacy in functional larynx preservation and in patient survival.
  • TAKE HOME MESSAGE: The treatment of most patients with laryngeal cancer with systemic therapy represents an opportunity to positively impact functional outcomes with an anatomically and functionally preserved larynx.
  • [MeSH-major] Adenocarcinoma / drug therapy. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Laryngeal Neoplasms / drug therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20429666.001).
  • [ISSN] 1744-7666
  • [Journal-full-title] Expert opinion on pharmacotherapy
  • [ISO-abbreviation] Expert Opin Pharmacother
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 80
  •  go-up   go-down


81. McCaffrey JC: Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology. Laryngoscope; 2006 Jan;116(1):1-11
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
  • Cox regression analysis demonstrated invasion of larynx and trachea were significant prognostic factors for poor outcome.
  • [MeSH-major] Adenocarcinoma, Follicular / secondary. Cadherins / blood. Esophageal Neoplasms / secondary. Laryngeal Neoplasms / secondary. Neoplasm Invasiveness / pathology. Thyroid Neoplasms / pathology. Tracheal Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16481800.001).
  • [ISSN] 0023-852X
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cadherins
  •  go-up   go-down


82. Stinn W, Arts JH, Buettner A, Duistermaat E, Janssens K, Kuper CF, Haussmann HJ: Murine lung tumor response after exposure to cigarette mainstream smoke or its particulate and gas/vapor phase fractions. Toxicology; 2010 Sep 10;275(1-3):10-20
MedlinePlus Health Information. consumer health - Smoking.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In order to develop such a model, A/J and Swiss SWR/J mouse strains, with a genetic susceptibility to developing lung adenocarcinoma, were whole-body exposed to diluted cigarette mainstream smoke at 0, 120, and 240 mg total particulate matter per m(3) for 6h per day, 5 days per week.
  • At the end of the inhalation period, epithelial hyperplasia, atrophy, and metaplasia were found in the nasal passages and larynx, and cellular and molecular markers of inflammation were found in the bronchoalveolar lavage fluid.

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Secondhand Smoke.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2010 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 20594951.001).
  • [ISSN] 1879-3185
  • [Journal-full-title] Toxicology
  • [ISO-abbreviation] Toxicology
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Gases; 0 / Particulate Matter; 0 / Tobacco Smoke Pollution
  •  go-up   go-down


83. Jayaprakash V, Natarajan KK, Moysich KB, Rigual NR, Ramnath N, Natarajan N, Reid ME: Wood dust exposure and the risk of upper aero-digestive and respiratory cancers in males. Occup Environ Med; 2008 Oct;65(10):647-54
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: In a hospital-based case-control study conducted at Roswell Park Cancer Institute, Buffalo, NY, USA, an examination was carried out to determine the effect of self-reported WD exposure on 1522 male UADR cancer cases (241 oral and oropharyngeal, 90 nasal cavity, nasopharyngeal and hypopharyngeal, 124 laryngeal, 809 lung and tracheal and 258 oesophagus and gastric cardia) and 1522 male controls, frequency matched on age and smoking history.
  • WD was associated with an 82-93% increased risk of squamous cell, small cell and adenocarcinoma of the lung and more than twice the risk of developing squamous cell carcinoma of the nasal cavity, nasopharynx and hypopharynx, with a significant dose-response relationship.
  • A significant increase in risk of laryngeal and lung cancers was noted for subjects regularly exposed to WD for >20 years.
  • CONCLUSION: WD exposure is a potential risk factor for UADR cancers, especially for cancers of the nasal cavity, nasopharynx, larynx and lung.

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Occupational Health.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18182588.001).
  • [ISSN] 1470-7926
  • [Journal-full-title] Occupational and environmental medicine
  • [ISO-abbreviation] Occup Environ Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Dust
  •  go-up   go-down


84. Ren JS, Freedman ND, Kamangar F, Dawsey SM, Hollenbeck AR, Schatzkin A, Abnet CC: Tea, coffee, carbonated soft drinks and upper gastrointestinal tract cancer risk in a large United States prospective cohort study. Eur J Cancer; 2010 Jul;46(10):1873-81
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • During 2,584,953 person-years of follow-up on 481,563 subjects, 392 oral cavity, 178 pharynx, 307 larynx, 231 gastric cardia, 224 gastric non-cardia cancer, 123 Oesophageal Squamous Cell Carcinoma (ESCC) and 305 Oesophageal Adenocarcinoma (EADC) cases were accrued.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published by Elsevier Ltd.
  • [Cites] J Natl Cancer Inst. 1994 Jun 1;86(11):855-8 [8182766.001]
  • [Cites] Cancer. 1993 Aug 15;72(4):1369-75 [8339227.001]
  • [Cites] Epidemiology. 1994 Nov;5(6):583-90 [7841239.001]
  • [Cites] Cancer Causes Control. 1995 Jan;6(1):57-67 [7718736.001]
  • [Cites] Cancer Causes Control. 1998 Mar;9(2):209-16 [9578298.001]
  • [Cites] Br J Cancer. 1999 May;80(3-4):614-20 [10408875.001]
  • [Cites] J Agric Food Chem. 2004 Dec 29;52(26):8268-71 [15612828.001]
  • [Cites] CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 [15761078.001]
  • [Cites] Asian Pac J Cancer Prev. 2005 Apr-Jun;6(2):202-7 [16101334.001]
  • [Cites] J Natl Cancer Inst. 2006 Jan 4;98(1):72-5 [16391374.001]
  • [Cites] Cad Saude Publica. 2006 May;22(5):889-900 [16680342.001]
  • [Cites] J Natl Cancer Inst. 2006 Aug 16;98(16):1158-61 [16912268.001]
  • [Cites] J Epidemiol. 2006 Sep;16(5):185-92 [16951537.001]
  • [Cites] Anticancer Agents Med Chem. 2006 Sep;6(5):389-406 [17017850.001]
  • [Cites] Eur J Gastroenterol Hepatol. 2007 Feb;19(2):171-6 [17273005.001]
  • [Cites] Ann Epidemiol. 2007 Oct;17(10):821-6 [17606381.001]
  • [Cites] Asia Pac J Clin Nutr. 2008;17 Suppl 1:245-8 [18296347.001]
  • [Cites] Arh Hig Rada Toksikol. 2008 Mar;59(1):11-8 [18407867.001]
  • [Cites] Cancer Causes Control. 2008 Aug;19(6):577-84 [18231869.001]
  • [Cites] Int J Cancer. 2009 Feb 1;124(3):670-7 [18973231.001]
  • [Cites] Am J Epidemiol. 2008 Dec 15;168(12):1425-32 [18974083.001]
  • [Cites] BMJ. 2009;338:b929 [19325180.001]
  • [Cites] Int J Cancer. 2009 Aug 1;125(3):491-524 [19415743.001]
  • [Cites] Cancer Causes Control. 2009 Oct;20(8):1303-8 [19430969.001]
  • [Cites] Int J Cancer. 2000 Jul 15;87(2):289-94 [10861489.001]
  • [Cites] Int J Cancer. 2000 Nov 15;88(4):658-64 [11058886.001]
  • [Cites] J Food Prot. 2001 Aug;64(8):1268-70 [11510675.001]
  • [Cites] Nutr Cancer. 2000;38(2):186-91 [11525596.001]
  • [Cites] Am J Epidemiol. 2001 Dec 15;154(12):1119-25 [11744517.001]
  • [Cites] Br J Cancer. 2002 Feb 1;86(3):346-7 [11875696.001]
  • [Cites] Gan To Kagaku Ryoho. 2002 Feb;29 Suppl 1:159-72 [11890101.001]
  • [Cites] J Laryngol Otol. 2002 Jul;116(7):523-31 [12238672.001]
  • [Cites] Zhonghua Liu Xing Bing Xue Za Zhi. 2003 Mar;24(3):192-5 [12816709.001]
  • [Cites] Oral Oncol. 2003 Oct;39(7):695-700 [12907209.001]
  • [Cites] Oral Oncol. 2004 Feb;40(2):207-13 [14693246.001]
  • [Cites] Aliment Pharmacol Ther. 2004 Mar 1;19(5):497-510 [14987318.001]
  • [Cites] Asian Pac J Cancer Prev. 2004 Jan-Mar;5(1):58-65 [15075007.001]
  • [Cites] Nutr Cancer. 1984;6(4):220-8 [6545578.001]
  • [Cites] J Natl Cancer Inst. 1986 May;76(5):823-31 [3457969.001]
  • [Cites] Nutr Cancer. 1987;10(1-2):103-13 [3112746.001]
  • [Cites] Cancer Res. 1989 Feb 15;49(4):1049-51 [2912550.001]
  • [Cites] Nutr Cancer. 1992;17(1):27-31 [1574442.001]
  • [Cites] Cancer Causes Control. 1994 Sep;5(5):401-8 [7999961.001]
  • (PMID = 20395127.001).
  • [ISSN] 1879-0852
  • [Journal-full-title] European journal of cancer (Oxford, England : 1990)
  • [ISO-abbreviation] Eur. J. Cancer
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z01 CP010196-02; United States / Intramural NIH HHS / / Z99 CA999999
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Intramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Coffee; 0 / Tea
  • [Other-IDs] NLM/ NIHMS192095; NLM/ PMC2891563
  •  go-up   go-down


85. Sánchez-Fructuoso A, Conesa J, Perez Flores I, Ridao N, Calvo N, Prats D, Rodríguez A, Barrientos A: Conversion to sirolimus in renal transplant patients with tumors. Transplant Proc; 2006 Oct;38(8):2451-2
Hazardous Substances Data Bank. SIROLIMUS .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: This prospective study of 29 patients included 2 patients with skin cancer (1 melanoma and 1 squamous cell carcinoma) and 27 patients who developed other tumors: lung (n = 6), prostate (n = 4), lymphoma (n = 2), colon adenocarcinoma (n = 2), kidney (n = 2), Kaposi sarcoma (n = 2), urothelium (n = 1), parotid (n = 1), larynx (n = 1), gastric (n = 1), breast (n = 1), tongue (n = 1), liver (n = 1), xanthoastrocytoma (n = 1), and aggressive angiomyxoma of the perineum (n = 1).

  • MedlinePlus Health Information. consumer health - Kidney Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17097964.001).
  • [ISSN] 0041-1345
  • [Journal-full-title] Transplantation proceedings
  • [ISO-abbreviation] Transplant. Proc.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Immunosuppressive Agents; AYI8EX34EU / Creatinine; W36ZG6FT64 / Sirolimus
  •  go-up   go-down


86. Horvat S, Mlinarić-Majerski K, Glavas-Obrovac L, Jakas A, Veljković J, Marczi S, Kragol G, Roscić M, Matković M, Milostić-Srb A: Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity. J Med Chem; 2006 Jun 1;49(11):3136-42
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Possible cytotoxic activity on human cervical adenocarcinoma (HeLa), larynx carcinoma (HEp-2), colon carcinomas (HT-29, Caco-2), poorly differentiated cells from lymph node metastasis of colon carcinoma (SW-620), mammary gland adenocarcinoma (MCF-7), and melanoma (HBL) cells were tested by the MTT assay.
  • Peptide analogues containing C(alpha alpha)-dialkylated glycine (Aaa1, 1) or C(alpha)-alkylated glycine (Aaa2, 2) amino acid residues showed antitumor activity against melanoma, larynx carcinoma, colon carcinomas, and colon metastasis cell lines in vitro.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16722632.001).
  • [ISSN] 0022-2623
  • [Journal-full-title] Journal of medicinal chemistry
  • [ISO-abbreviation] J. Med. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Amino Acids; 0 / Antineoplastic Agents; 0 / Oligopeptides; 0 / tyrosyl-(1-adamantyl)glycyl-glycyl-phenylalanyl-methionine; 58569-55-4 / Enkephalin, Methionine; PJY633525U / Adamantane
  •  go-up   go-down


87. Erelel M, Yakar F, Yakar A, Acunas B: Radiofrequency ablation for inoperable lung cancer: a case report. J Bronchology Interv Pulmonol; 2009 Jul;16(3):199-203

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • He had a remote history of larynx and lung cancer.
  • CT-guided transthoracic fine needle aspiration biopsy revealed adenocarcinoma but the procedure was complicated by pneumothorax and hypercapnic respiratory failure.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23168554.001).
  • [ISSN] 1944-6586
  • [Journal-full-title] Journal of bronchology & interventional pulmonology
  • [ISO-abbreviation] J Bronchology Interv Pulmonol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


88. Dogan G, Kizilay A: Painful cutaneous metastasis in a patient with laryngeal adenocarcinoma. Clin Exp Dermatol; 2007 Mar;32(2):225-6
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Painful cutaneous metastasis in a patient with laryngeal adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / secondary. Laryngeal Neoplasms. Skin Neoplasms / secondary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17342803.001).
  • [ISSN] 0307-6938
  • [Journal-full-title] Clinical and experimental dermatology
  • [ISO-abbreviation] Clin. Exp. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] England
  •  go-up   go-down


89. Tywończuk-Szulc M: [Carcinoma of the larynx in region of Warmia and Mazury (1998-2007): epidemiological and clinical analysis and assessment of treatment results]. Otolaryngol Pol; 2010 Nov-Dec;64(6):403-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Carcinoma of the larynx in region of Warmia and Mazury (1998-2007): epidemiological and clinical analysis and assessment of treatment results].
  • [MeSH-major] Adenocarcinoma / epidemiology. Adenocarcinoma / therapy. Carcinoma, Squamous Cell / epidemiology. Carcinoma, Squamous Cell / therapy. Laryngeal Neoplasms / epidemiology. Laryngeal Neoplasms / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21302512.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] Journal Article
  • [Publication-country] Poland
  •  go-up   go-down






Advertisement